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 Changes to the embryonic environment that occur within the first few days of 
development can have significant effects on subsequent fetal development. The following 
studies investigate the effects of progesterone-deprivation during the early 
preimplantation period in the mare. The first study described embryo morphology 
(diameter, stage, and quality grade) collected from mares with induced aluteal cycles. 
The second study evaluated the effect of induced aluteal cycles on the future fertility of 
embryo collections as a potential method for cycle manipulation of embryo donor mares. 
The third study characterized embryonic and endometrial transcript expression of 
progesterone-mediated transcripts as well as those related to normal embryo growth and 
pregnancy establishment during induced aluteal cycles. Finally, the fourth study 
evaluated the potential for the successful establishment of pregnancy when 
preimplantation embryos were deprived of progesterone. Embryos developed in a 
progesterone-deprived environment were developmentally delayed by all parameters 
evaluated. A significant effect was seen on the transcript expression of embryos and 
endometrium collected from progesterone-deprived cycles in the mare. Embryos deprived 
of progesterone during the early preimplantation period demonstrated delayed embryonic 
vesicle growth compared to control cycles. No effect was seen on the future fertility of 
embryo collections after utilizing progesterone-deprived cycles. The results of these 
studies elucidate the significance of adequate progesterone levels beginning immediately 
post-ovulation in the mare. 
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CHAPTER 1: GENERAL INTRODUCTION 
1.1 General Introduction 
 The corpus luteum (CL) is a temporary endocrine structure formed on the ovary 
[1.1]. This structure plays an integral role in the establishment and maintenance of 
mammalian pregnancy. In the mare, this structure is the primary source of progesterone 
during the first one third of gestation and progesterone is detectable at high 
concentrations in maternal plasma (>10 ng/mL) [1.2, 1.3]. Progesterone plays a role in 
regulating uterine quiescence and nourishes the embryo prior to implantation by the 
production of histotroph [1.4, 1.5]. Adequate progesterone levels are required to maintain 
pregnancy and embryonic loss in the mare has been associated with plasma progesterone 
levels < 2 ng/mL [1.6]. The equine pregnancy is unique among mammals with an 
extended period of preimplantation embryo development prior to attachment and 
placentation [1.7]. Recent studies have investigated the effects of periovulatory doses of 
prostaglandin F2α (PGF2α) on luteal function, embryo development and pregnancy in 
mares [1.7-1.13].  
1.2 Corpus Luteum  
 The preovulatory follicle undergoes many changes prior to ovulation in 
preparation for luteogenesis. During late estrus and prior to ovulation, the preovulatory 
follicle becomes less responsive to gonadotropins [1.14]. This results in a shift of steroid 
hormone secretion from estradiol to progesterone within the follicle [1.14]. After 
ovulation of the dominant follicle, the CL forms as a transient endocrine gland that 
maintains the luteal phase of the estrous cycle [1.1]. The rapid proliferation of capillaries 
that occurs during the early stage of CL development has been compared to the 
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vascularization of solid tumors [1.15]. At the time of ovulation, intense changes occur in 
the endothelium of vessels surrounding the follicle [1.15]. Within 48 hours a new 
complex network of vessels has developed and invaded the previously avascular 
granulosa cell layers, which induces luteinization and later nourishes the CL [1.15]. 
Several factors have been implicated in the regulation of CL angiogenesis including 
vascular endothelial growth factor, cytokines, tumor necrosis factor α, and interferon 
gamma [1.1, 1.16]. 
 The CL forms on the ovary after ovulation. In most mammals the follicular theca 
and granulosa cells begin a rapid turnover to form the small and large luteal cells 
respectively [1.17]. The resulting large luteal cells are relatively unresponsive to LH and 
secrete high basal quantities of progesterone whereas small luteal cells secrete low basal 
quantities of progesterone and are responsive to LH [1.18, 1.19]. The histology of the 
equine CL differs as only the granulosa cells of the preovulatory follicle contribute to the 
fully formed equine CL [1.20]. In contrast to other species, the theca interna cells 
degenerate at ovulation in the mare and the cause for cell degeneration remains to be 
elucidated (apoptosis vs. necrosis)  [1.20, 1.21]. 
 In the absence of pregnancy, luteolysis occurs naturally at the end of diestrus to 
allow a return to estrus and chance for rebreeding. The luteolytic process requires 
multiple triggering factors working synergistically which include PGF2α, nitric oxide, 
and cytokines [1.22-1.25]. As a result, the CL undergoes both functional and structural 
regression; resulting in a reduction in progesterone production and changes in luteal 
tissue morphology. It has been demonstrated that apoptosis in the CL is essential in 
regulating cell number and is mediated by nitric oxide as well as cytokine receptors such 
	 3	
as Fas ligand [1.22]. A decrease in progesterone production has been described as a direct 
negative effect of PGF2α [1.26]. The endogenous luteolysin, PGF2α, is released from the 
endometrium in a pulsatile manner [1.27-1.29]. Furthermore, the secretion of PGF2α is 
stimulated by the pulsatile release of oxytocin, which is affected by the concentration of 
endometrial oxytocin receptors [1.30]. Endometrial oxytocin receptor concentration has 
been demonstrated to be lowest during estrus and highest on Day 14 in non-pregnant 
mares [1.30]. Additionally, oxytocin receptor affinity is lower in pregnant than non-
pregnant mares [1.30].  
 The CL is a key component of diestrus and manipulation of the equine estrous 
cycle often centers on the presence or absence of a CL. Hormonal manipulation focuses 
on either the termination of or prolonging the lifespan of the CL. Exogenous 
progestagens have been administered to mimic the presence of a CL in an attempt to 
synchronize ovulation of a group of mares [1.31]. The success of this technique varies 
greatly according to the stage of the cycle and average follicle size when treatment is 
administered [1.32]. Conversely, termination of a CL is achieved by administration of 
exogenous PGF2α with reports of its use inducing luteolysis as early as the 1970s [1.33, 
1.34].   
1.3 Prostaglandin F2 Alpha  
 There are a several aspects of the reproductive physiology and endocrinology of 
the mare that makes them unique among large animals, one of which is the relationship 
between luteal blood flow and luteolysis [1.35]. Horses lack countercurrent exchange 
between the uterine vein and the ovarian artery compared to ruminants [1.36]. As a result 
of this unique anatomy, PGF2α must travel systemically from the uterus to the ovary in 
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mares vs. local action in ruminants where the uterine vein is closely associated with the 
ovarian artery [1.36]. Additionally, the plasma clearance of PGF2α is five times slower in 
mares compared to heifers, resulting in a longer half-life [1.37]. It has been described that 
the equine is approximately 18 times more sensitive to the luteolytic effects of systemic 
administration of PGF2α than the bovine CL [1.36, 1.38]. An in vitro study demonstrated 
that equine luteal cell membrane preparations had an affinity for PGF2α 10 times greater 
than bovine luteal cell preparations [1.39]. A combination of these factors; the high 
affinity of the mare CL to binding of PGF2α and the relatively slow metabolic clearance, 
account for the greater sensitivity of the mare CL compared to other domestic species 
[1.40]. 
 The administration of PGF2α and its analogues have been utilized to induce 
luteolysis in mares for over 5 decades. For almost as long, it was believed that the CL 
was refractory to exogenous administration of PGF2α and luteolysis could not be induced 
prior to Day 5 [1.41]. Only recently have studies challenged this dogma. In the last two 
decades multiple studies have investigated the effects of periovulatory doses of PGF2α 
on luteal function and pregnancy rates in mares [1.7-1.12, 1.42, 1.43]. Several studies 
with varying single daily doses of PGF2α (cloprostenol) administered on Days 0, 1, and 2 
post-ovulation had a transient effect on plasma progesterone concentrations [1.7, 1.11, 
1.12]. In mares treated with 3 periovulatory doses of PGF2α, a decrease in plasma 
progesterone concentrations was observed, but levels rose to > 2.0 ng/mL by Days 4 and 
5 in those studies [1.7, 1.11, 1.12]. Interestingly, a model has been developed which 
reliably prevents normal luteal function in all treated mares administered serial doses of 
PGF2α beginning within 12 hours of ovulation [1.8, 1.10]. This model demonstrates that 
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the early equine CL is responsive to PGF2α and normal luteal function can be completely 
interrupted if serial doses are administered during the early postovulatory period [1.8, 
1.10].  
1.4 Progesterone 
 Progesterone has long been considered the hormone essential for conception and 
establishment of pregnancy in mammalian reproduction. It has been demonstrated that in 
horses the CL is the exclusive source of progesterone during the first 150 days of 
gestation [1.3]. Sufficient progesterone concentrations are essential for maintaining 
pregnancy during the early postovulatory period between Days 2 to 5 [1.7]. High 
embryonic death occurs in the equine and it has been estimated that 30-40% of 
pregnancies are lost during the first 2 weeks following high fertilization rates [1.44]. The 
cause of early embryonic death is often unknown but has been attributed to 
hypoluteoidism [1.3, 1.45]. It has been described that increased embryo survival is more 
likely to occur when circulating progesterone concentrations are > 4 ng/mL compared to 
decreased survival when < 2 ng/mL [1.6].  
 Progesterone maintains uterine quiescence by reducing the number of gap 
junctions for uterotonic hormones, such as prostaglandin F2α and oxytocin on the 
myometrium [1.46, 1.47]. The endometrium is primed by progesterone to produce the 
uterine histotroph, which is essential to conceptus survival and growth [1.48]. The 
histotroph contains a multitude of proteins that are essential for the survival, growth and 
development of the preimplantation embryo [1.49]. It has been demonstrated in sheep 
that the endometrial gland density is directly related to the survival and development of 
the conceptus [1.50]. Additionally, studies utilizing an ovine uterine gland knockout 
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model have demonstrated that functional endometrial glands and their secretions are 
necessary to ensure conceptus elongation and survival [1.51].    
1.5 The Early Preimplantation Period  
 During the early preimplantation period there are again differences present in the 
equine compared to that of other domestic species. Implantation in the horse is protracted 
compared to other domestic animals; an extended period of conceptus development 
precedes implantation and placentation [1.51]. Due to the prolonged preimplantation 
period in the mare, adequate histotroph is especially important to nurture the embryo and 
maintain pregnancy [1.52]. The conceptus-initiated signal for maternal recognition of 
pregnancy (MRP) has yet to be elucidated in the mare compared to other domestic 
species. Certain factors have been found to be essential so the MRP signal can be 
released such the equine conceptus mobility throughout the uterus between Day 7 and 17 
[1.53]. Additionally, an immunosuppressive protein called “early pregnancy factor,” an 
extracellular form of heat shock protein 10, has been described in the mare [1.54, 1.55]. 
These factors ensure that MRP can properly occur to ensure continuation and secretory 
function of the CL beyond its normal lifespan [1.53]. This maintains the uterus in the 
appropriate progestational progesterone rich environment to support the developing 
pregnancy [1.53].  
 The equine embryo enters the uterus on Day 6, typically a morula at 
approximately 150 μm in diameter [1.56]. Between Day 6 to Day 8 the equine embryo 
rapidly grows and develops into a blastocyst then expands [1.57]. The embryo begins to 
form the capsule between the trophoblast and the inner surface of the zona pellucida 
[1.57]. Shortly after capsule formation is complete, the zona pellucida is shed from the 
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equine embryo [1.57]. The capsule is a structurally strong, acellular mucin-like 
glycoprotein matrix essential to pregnancy and protection of the embryo [1.58]. The 
lipocalin P19 produced by the equine endometrium is essential to the development of the 
capsule as it has been demonstrated that embryos developed in vitro do not develop a 
complete and cohesive capsule or shed their zona pellucida [1.59, 1.60]. Furthermore, it 
has been elucidated that P19 is mediated by progesterone and is one of the most abundant 
proteins found in the equine uterine histotroph [1.59].  
1.6 Scope of the Dissertation 
 It has been described that progesterone production as early as Day 2 post-
ovulation can have a significant effect on pregnancy outcome in the mare [1.7]. 
Furthermore, hypoluteoidism has been implicated as a factor of EED in the mare [1.3, 
1.45]. The occurrence of EED each breeding season results in significant economic loss 
to the equine industry. The aim of the dissertation was to investigate the effects of 
progesterone-deprivation on the equine embryo and endometrium during the early 
preimplantation period in the mare. These studies may further elucidate the effects of 
hypoluteoidism on EED in the mare. The following series of studies utilized a novel in 
vivo model developed in our laboratory to prevent the formation of a functional CL 
immediately post-ovulation by administering serial doses of PGF2α beginning within 12 
hours post-ovulation [1.8, 1.10]. Mares treated according to this protocol consistently 
have mean concentrations of plasma progesterone < 1.0 ng/mL (induced aluteal cycles) 
throughout the study period [1.8, 1.10]. 
  The objective of the first study was to describe the morphology of embryos 
(diameter, stage, and quality grade) collected from mares with induced aluteal cycles. 
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The second study sought to characterize embryonic and endometrial expression of 
progesterone-mediated transcripts as well as those related to normal embryo growth, 
pregnancy establishment, and prostaglandin synthesis during induced aluteal cycles. The 
objective of the third study was to evaluate the difference in early pregnancy 
development when preimplantation embryos were deprived of progesterone. Finally, the 
fourth study sought to evaluate the effect of induced aluteal cycles on the future fertility 
of embryo collections as a potential method for cycle manipulation of embryo donor 
mares. The results of these studies are described in detail in the following chapters. 
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CHAPTER 2: MORPHOLOGICAL EVALUATION OF DAY 8 EMBRYOS 
DEVELOPED DURING INDUCED ALUTEAL CYCLES IN THE MARE1  
 
2.1 Summary 
 A novel in vivo model utilizing serial administrations of PGF2α to induce aluteal 
cycles in the mare was used to evaluate the effects of progesterone-deprivation on the 
morphology of in vivo preimplantation embryos. We hypothesized that equine embryos 
produced during induced aluteal cycles (AL) would be developmentally affected, 
characterized by earlier embryo stage at collection, smaller embryo diameter, and lower 
quality grade, compared with those collected on the same day post-ovulation from control 
cycles during diestrus (high progesterone; > 4 ng/mL). Seven cyclic mares with a median 
age of 6.5 years (range 3-16) were utilized in a crossover design. Mares in estrus were 
artificially inseminated to a fertile stallion and randomly assigned to control or AL 
groups. Mares received either saline solution (control mares) or PGF2α (AL mares), 
twice daily on days 0, 1, and 2 and once daily on days 3 and 4. Serial blood samples were 
collected daily during estrus and until the day of embryo collection 8 days after 
ovulation. Mares were monitored until they returned to estrus, and artificially 
inseminated. Mares were switched to the opposite treatment group only after a successful 
embryo collection occurred during the previous cycle. Only cycles that produced 
embryos were used for analyses. No significant rise in progesterone was observed in the 
AL group with mean concentrations of plasma progesterone remaining < 1.0 ng/mL from 
ovulation until embryo collection on Day 8. This is in sharp contrast to the control  
																																																								
1	This chapter previously appeared as Leisinger CA, Medina V, Markle ML, Paccamonti 
DL, Pinto CRF. Morphological evaluation of Day 8 embryos developed during induced 
aluteal cycles in the mare. Theriogenology 2018;105:178-83. 
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(luteal) cycle where a post-ovulatory rise in plasma progesterone was observed. The 
mean daily concentrations of plasma progesterone were significantly higher in control vs. 
AL group beginning at Day 3 and remained so until Day 8. The mean (±SEM) embryo 
diameter of AL embryos was 171 ± 5 μm compared to 756 ± 99 μm for control embryos. 
The majority of the Day 8 AL embryos were classified as morulae (3/9) or early 
blastocysts (5/9) with only 2 embryos of quality grade 1 compared to the Day 8 control 
embryos that were mostly expanded blastocysts (6/7) with 5 of 6 being of quality grade 1. 
This study shows that serial administrations of PGF2α were able to prevent significant 
rises in plasma progesterone, thus inducing aluteal cycles characterized by a 
progesterone-deprived environment for developing embryos. Embryos collected from 
induced aluteal cycles were adversely affected as demonstrated by a lower quality grade, 
smaller diameter and earlier embryo stage at collection when compared to control 
embryos.  
2.2 Introduction 
 There is strong evidence to support a crucial role for progesterone in regulating 
early pregnancy events in the horse, including preimplantation embryo development and 
embryo-maternal signaling for pregnancy. The correct maternal-embryo crosstalk during 
the preimplantation period is essential to establish pregnancy, specifically by ensuring 
corpus luteum maintenance and progesterone secretion [2.1]. Throughout the first 150 
days of pregnancy in the mare, progesterone is detectable at high concentrations in the 
maternal plasma (> 10 ng/mL) and is produced by the primary and secondary corpora 
lutea (CL) of the ovary [2.2]. During the first 40 days of gestation in the mare, the 
primary CL is the sole source of progesterone [2.3]. One of the primary determinants of 
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an adequate environment conducive to the establishment of pregnancy is the continued 
supply of ovarian progesterone from the CL [2.1]. Progesterone is essential to provide the 
appropriate intrauterine environment for conceptus development [2.4]. Progesterone 
induces the production of endometrial histotroph, which is the primary conceptus 
nutrition until placentation [2.5]. The requirement for progesterone to drive uterine 
secretions necessary for conceptus development has been demonstrated in a variety of 
ways. For example, ovariectomized mares established and maintained pregnancy when 
administered only exogenous progesterone prior to the embryo transfer and during the 
first 100 days of gestation [2.6]. 
 In addition to the production of endometrial histotroph, progesterone plays a role 
in the establishment and maintenance of early pregnancy by ensuring myometrial 
quiescence [2.7]. It reduces uterine contractility and the number of gap junctions and 
receptors for uterotonic hormones, such as prostaglandin F2α and oxytocin on the 
myometrium [2.8, 2.9]. These are key functions for the initiation of maternal recognition 
of pregnancy (MRP) events in the mare. The events of MRP describe embryo-maternal 
communication during early pregnancy that prevents luteolysis to ensure ongoing 
progestational support that is vital for embryo development [2.10]. If proper MRP does 
not occur, early embryonic death (EED) may result. High embryonic death and 
significant economic loss occurs during early pregnancy in the equine. It is estimated that 
30-40% of pregnancies are lost within 2 weeks following high fertilization rates [2.11]. 
The cause of EED remains largely unknown during the early period and has been 
attributed to a variety of factors. One of these factors may be hypoluteoidism, which is a 
condition characterized by low levels of progesterone incompatible to support early 
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pregnancy in the mare [2.3, 2.12]. It has been described that embryonic loss is more 
likely to occur when the circulating progesterone concentration is < 2 ng/mL compared to 
increased embryonic survival associated with progesterone concentrations > 4 ng/mL 
[2.13].  
 For the present study, we developed a novel model to induce aluteal cycles, 
characterized by a progesterone-deprived environment following ovulation. 
Administrations of serial doses of PGF2α beginning during the early post-ovulatory 
period have been shown to alter luteal development and function as evidenced by 
changes in concentrations of plasma progesterone [2.14-2.22]. Based on these effects, a 
series of studies in our laboratory refined a model to prevent the formation of a functional 
corpus luteum immediately post-ovulation (antiluteogenesis) [2.14]. In this model serial 
administration of PGF2α beginning within 12 hours post-ovulation (Day 0) was 
administered twice daily on Days 0, 1, and 2 and then once daily on Days 3 and 4 [2.14]. 
Mares treated according to this protocol consistently had mean concentrations of plasma 
progesterone < 1.0 ng/mL throughout (and after) the study period Days 0–5 post-
ovulation [2.14]. In a subsequent proof of concept study, we have also reported that 
embryonic development could occur in mares that were artificially inseminated and 
underwent antiluteogenic treatment (serial administration of PGF2α) after ovulation 
[2.19].  Furthermore, embryos developing in this low progesterone environment could be 
“rescued” by the administration of exogenous progestin [2.19]. Therefore, this study was 
designed to evaluate the effects of progesterone-deprivation on in vivo embryos collected 
from progesterone-deprived cycles in the mare during the early preimplantation period, 
specifically days 0–8 post-ovulation. The objective of this study was to describe the 
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morphology of embryos (diameter, stage, and quality grade) collected from mares with 
induced aluteal cycles. We hypothesized that equine embryos produced during induced 
aluteal cycles (progesterone-deprived environment; < 1.0 ng/mL) would be 
developmentally affected, characterized by earlier embryo stage at collection, smaller 
embryo diameter, and lower quality grade, compared with those collected on the same 
day post-ovulation from control cycles during normal diestrus.   
2.3 Materials and Methods 
The Institutional Animal Care and Use Committee of Louisiana State University 
School of Veterinary Medicine approved all experimental protocols. The work was 
performed in a USDA-registered National Institute of Health-assured, and AAALAC 
International accredited animal facility in accordance with The Guide for the Care and 
Use of Laboratory Animals [2.23]. Seven cyclic Thoroughbred mares with a median age 
of 6.5 years (range 3-16) were utilized in a balanced crossover design from March to 
September 2016 in Baton Rouge, LA. Mares were randomly assigned to one of two 
treatment groups: control (normal diestrus) or induced aluteal (AL). Mares remained in 
the first assigned treatment group until a successful embryo collection. Immediately after 
the first successful embryo collection, they were assigned to the opposite treatment group 
and remained in that treatment group until a successful embryo collection. This study 
design resulted in the production of paired embryos from control and AL cycles from the 
same mare for analyses. 
Mares were monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm, 
Bothell, WA) throughout the study period. Mares in estrus as determined by the presence 
of uterine edema and with a follicle > 35 mm diameter were treated once with 2000 IU of 
	 19	
human chorionic gonadotropin (hCG) administered intravenously (Chorulon, Merck 
Animal Health, Kenilworth, NJ). Mares were artificially inseminated every other day 
until ovulation was detected with ≥ 1 x 109 total motile spermatozoa from one stallion of 
known fertility. Reproductive examinations by ultrasonography were performed twice 
daily after insemination until detection of ovulation. After ovulation, mares were 
randomly assigned to one of two treatment groups: control (normal diestrus) or induced 
aluteal (AL). The AL mares were treated according to a protocol previously described 
[2.14]. Briefly, mares were treated twice daily with PGF2α (10 mg, IM, Lutalyse, 
dinoprost tromethamine, Zoetis, Florham Park, NJ) on days 0, 1, and 2, and once daily on 
days 3 and 4 [2.14]. The control group was treated on the same schedule with saline 
solution (2 mL, IM). Embryo collections were performed on Day 8 post-ovulation. 
Embryos were collected in an aseptic manner using Lactated Ringers Solution (LRS) 
with no supplementation (MWI Veterinary Supply, Boise, ID). The uterus was lavaged 
with 0.5 to 1 L of LRS at a time and an average 4 to 6 L of LRS was used in total. 
Recovered embryos were classified using a stereomicroscope (SMZ800, Nikon, Melville, 
NY) according to stage of development and assigned a quality grade on a scale of 1-4 
[2.24]. Briefly, quality grade 1 was assigned to embryos with no abnormalities, spherical 
shape, uniform size, color and texture; grade 2 embryos had minor imperfections 
demonstrated by some extruded blastomeres, and slight irregularities in shape, size, color 
or texture; grade 3 embryos had moderate imperfections demonstrated by large 
percentage of extruded blastomeres, partial collapse of blastocele, or moderate shrinkage 
of trophoblast from zona pellucida; grade 4 embryos had complete degeneration and 
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embryonic death [24]. Additionally, embryos were photographed and their diameter 
measured (Nikon DSI-Fi2 camera with DS-L3 camera control, Nikon, Melville, NY).  
 Mares were monitored for a return to estrus by ultrasonography every other day 
after embryo collection. Once in estrus, mares were artificially inseminated and managed 
as described above. Mares remained in the same treatment group until an embryo was 
successfully collected. After a successful embryo collection, mares were assigned to the 
opposite treatment group. Only control or AL cycles with a successful embryo collection 
were used for statistical analyses. 
 Serial blood samples were collected from the time mares ovulated (Day 0) until 
embryo collection 8 days post-ovulation in both control and AL groups. Plasma was 
harvested and stored at -20° C until assayed for progesterone. Concentrations of plasma 
progesterone were determined by a progesterone radioimmunoassay (RIA). For the 
progesterone RIA, both the intraassay and interassay coefficients of variants were < 15%. 
A technician blinded to treatment protocols and groups performed the progesterone 
assays using a MP Biomedical double antibody approach as previously described [2.25].  
 Statistical significance for all data analyses was set at P ≤ 0.05. Data for embryo 
diameter was analyzed using a one-tailed paired t-test and data for stage of embryo 
development and quality grade were analyzed using a one-tailed Wilcoxon signed-rank 
test. Concentrations of plasma progesterone were analyzed by ANOVA for repeated 
measures. All statistical analyses were carried out using Sigma Plot V12.5 (Systat 





 A total of 7 successful embryo collections were recorded in both the control group 
and the AL group. A total of 7 embryos were collected from control embryo collections 
and a total of 9 embryos were collected from AL embryo collections as two mares had 
double ovulations in the AL cycles (Table 2.1). Overall the stage of embryo collected 
from control vs. AL cycles differed significantly (p < 0.01). In the control cycles, 86% 
(6/7) of embryos collected on Day 8 were classified as expanded blastocysts and 14% 
(1/7) were classified as blastocysts (Table 2.1, Fig. 2.1). In contrast, embryos collected 
from AL cycles on Day 8 were 33% (3/9) morulae, 56% (5/9) early blastocysts and 11% 
(1/9) blastocysts (Table 2.1, Fig. 2.1). Furthermore, the mean embryo diameter differed 
significantly in control vs. AL groups, 756 ± 99 μm vs. 171 ± 5 μm, respectively (p < 
0.001) (Table 2.1, Fig. 2.1). Additionally, the quality grades of AL embryos (2 ± 0.26) 
was significantly lower than that of control embryos (1 ± 0.18), (p < 0.05) (Table 2.1). 
 No rise in plasma progesterone was observed in the AL group with mean 
concentrations remaining < 1.0 ng/mL from Day 0 until embryo collection on Day 8 (Fig. 
2.2). This is in contrast to the control (luteal) group where a post-ovulatory rise in 
progesterone was documented (Fig. 2.2). The mean concentration of progesterone in the 
control group rose to 2.8 ng/mL on Day 2, in contrast to a mean concentration of 
progesterone of 0.7 ng/mL in the AL group (Fig. 2.2). The mean daily concentration of 
progesterone of mares in the AL group remained < 1.0 ng/mL throughout the duration of 
the study (Fig. 2). The mean daily concentrations of progesterone differed significantly 
between control vs. AL group beginning on Day 3 and remained so through Day 8 (p < 
0.001) (Fig. 2).  
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Table 2.1 Developmental stage, quality grade, and diameter of embryos recovered Day 8 
post-ovulation from control and induced aluteal cycles in each of the seven mares 
enrolled in the study.  
MARE 
ID 





















1 1122 Blastocyst 1 195 
3 Expanded 
blastocyst 








2 600 Morula 3 151 
5 Expanded 
blastocyst 
1 884 Morula 1 151 
6 Expanded 
blastocyst 





1 1006 Morula 3 178 
 
2.5 Discussion 
 The present study utilized a novel in vivo model to evaluate the effects of lack of 
progesterone on early embryo development in the mare. Progesterone-deprived (aluteal) 
cycles defined by mean plasma progesterone < 1.0 ng/mL were induced in all mares 
subjected to serial PGF2α treatments in the AL group. The serial administration of 
PGF2α beginning within 12 hours of ovulation had a significant effect on the developing 
corpus luteum prior to Day 3 post-ovulation. The absence of a significant rise in 
progesterone after ovulation in mares in the AL group indicated that early luteal cells are 
	 23	
 
Fig. 2.1. Two pairs of embryos collected 8 days post-ovulation from control and induced 
aluteal cycles of two different mares. These embryo pairs illustrate the profound effect of 
progesterone-deprivation on embryo stage and diameter. Pairs of the same letter indicate 
the embryo was collected from control and induced aluteal cyles in the same mare. a1) 
An expanded blastocyst measuring 884 μm in diameter from a control cycle. a2) A 
morula measuring 151 μm in diameter from an induced aluteal cycle. b1) An expanded 
blastocyst measuring 1031 μm in diameter from a control cycle. b2) A morula measuring 







Fig. 2.2 Mean (± S.E.M.) daily concentrations of plasma progesterone in control and 
induced aluteal treatment groups. During the induced aluteal treatment, note that serial 
administration of PGF2α immediately post-ovulation twice daily on Days 0, 1, and 2, 
then once daily on Days 3 and 4 caused the mean daily concentrations of plasma 
progesterone to remain below 1.0 ng/mL. This is in contrast to the control (luteal) cycle 
where a post-ovulatory rise in progesterone was observed. The mean daily concentrations 
of plasma progesterone differed significantly in control vs. aluteal group beginning at 
Day 3 until Day 8 (*; p < 0.001) 
 
being affected by PGF2α much earlier than previously thought. The plasma concentrations 
of progesterone of aluteal cycles contrasted greatly to that of control cycles resulting in a 
clearly defined progesterone-deprived environment following ovulation in the mare. 
Additionally, the embryo quality and stage of development were adversely affected in 
Day 8 embryos collected from AL cycles when compared with Day 8 embryos collected 
from control cycles.  
	 25	
	 To our knowledge this is the first study describing in vivo embryo development in 
a progesterone-deprived environment from Day 0 to Day 8 followed by embryo 
collection and evaluation. The present study utilized a previously validated model 
administering serial PGF2α treatments beginning within 12 hours of ovulation to reliably 
prevent normal luteal function (antiluteogenesis) in the mare [2.14]. Several studies have 
been conducted evaluating the effects of periovulatory doses of PGF2α on early luteal 
function and pregnancy rates in the mare [2.20-2.22]. These studies resulted in a transient 
interruption of early CL development when varying single daily doses of PGF2α 
(cloprostenol) were administered on Days 0, 1, and 2 post-ovulation as an approach to 
treat delayed uterine clearance in mares following breeding [2.20-2.22]. In those studies, 
concentrations of plasma progesterone did remain low for several days following 
ovulation in mares treated with three periovulatory doses of PGF2α administered once 
daily [2.20-2.22]. By days 4 and 5 after ovulation mares in those studies experienced 
resurgence in luteal function as concentrations of plasma progesterone rose above 2.0 
ng/mL [2.20-2.22]. These results are in sharp contrast to the present study where serial 
administration of eight doses of PGF2α beginning within 12 hours of ovulation (Day 0) 
and continuing until Day 4 completely prevented the formation of a functional CL in all 
treated mares. As a result, aluteal cycles, as defined by mean plasma progesterone < 1.0 
ng/mL, were induced in all mares throughout the study period when subjected to serial 
PGF2α treatments in the AL group.  
 In this study, the concentrations of plasma progesterone were significantly altered 
in the AL group where mean concentrations remained < 1.0 ng/mL from ovulation (Day 
0) until embryo collection (Day 8). This contrasted drastically to the control group where 
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mean concentrations of plasma progesterone were > 2.0 ng/mL beginning on Day 2 and a 
typical diestrus rise was observed throughout the study period. Sufficient progesterone 
concentrations are crucial for maintaining pregnancy during the early stages of CL 
development [2.22]. The uterine histotroph is thought to be especially important for 
conceptus survival and development in sheep, cattle, pigs, and especially in horses, in 
which an extended period of preimplantation conceptus development precedes 
attachment and placentation [2.26]. Studies utilizing ovine uterine gland knockout model 
ewes have shown the importance of functional endometrial glands and their secretions to 
preimplantation conceptus development and survival [2.26]. Numerous proteins secreted 
by the equine endometrium and vital to the development of the conceptus are 
progesterone dependent. One of the most abundant proteins of the equine uterine 
histotroph is P19, a lipocalin important in the assembly of the embryonic capsule [2.27]. 
Due to the administration of multiple doses of PGF2α beginning immediately post 
ovulation, we were able to completely prevent normal luteal formation (antiluteogenesis) 
as demonstrated by mean concentrations of plasma progesterone remaining < 1.0 ng/mL 
in all PGF2α-treated mares. The resulting progesterone-deprivation for the duration of the 
study likely had unfavorable effects on the development of uterine histotroph. 
 It has been demonstrated in several species that progesterone plays a key role in 
regulating gamete transport through the uterine tube. One aspect that makes the equine 
embryo unique is the prolonged transport through the oviduct lasting 6 days [2.28] 
Progesterone has been shown to play a crucial role in regulating ciliary beat frequency in 
vitro in the mouse, cow and human and in vivo in the guinea pig [2.29-2.32]. Regulation 
of ciliary motility is essential to facilitate the meeting of gametes and subsequent 
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transport of tubal stage embryos [2.29]. Additionally, the binding of progesterone 
receptor β in human oviductal epithelium affects smooth muscle relaxation, which is an 
important mechanism of oocyte transport from the ampulla to isthmus portion of the tube 
[2.30]. A progesterone-deprived environment may alter the day the embryo enters the 
uterus due to delayed transport through the uterine tube resulting in an altered embryo-
maternal interaction.  
 When equine embryos enter the uterus they are typically a late morula measuring 
approximately 150 μm in diameter [2.33]. They rapidly develop from a morula to an 
expanded blastocyst one to two days after entering the uterus. A normal Day 8 equine 
embryo should be an expanded blastocyst, visible to the naked eye with a diameter of 
500-1000 μm [2.33]. The Day 8 embryos collected in the control group displayed the 
expected characteristics of normal embryos. All of the control embryos collected except 
one were classified as expanded blastocysts and were between 600-1122 μm in diameter. 
This is in sharp contrast to the Day 8 AL embryos that were much earlier in development 
with approximately half of the embryos classified as early blastocyst and one third 
classified as morula with diameters between 151-195 μm. Furthermore, the quality of the 
AL embryos was significantly lower than the control embryos, indicating a negative 
effect of progesterone-deprivation on normal embryonic development.  
 In the equine embryo, coalescence of the endoderm colonies on the inside of the 
trophoblast at Day 8 completes yolk sac formation, which in turn initiates functional 
changes in the conceptus [2.34]. It has been described that the equine conceptus initiates 
steroidogenesis as early as Day 6 based on histochemical evidence of 3β-HSD [2.35]. 
However, stain intensities of 3β-HSD in Day 6 and 7 blastocysts are weaker with 
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measureable amounts of progesterone, androgens, and estrogens isolated from Day 8 
blastocyst in the horse [2.35]. Once the yolk sac has completely formed, it secretes 
growth hormones, expresses proteins, and synthesizes and metabolizes steroids [2.34]. By 
Day 12 the equine conceptus produces significant quantities of estrogens and this activity 
continues to increase until Day 20 [2.35, 2.36]. It is likely that conceptus-derived 
estrogens, acting via endometrial estrogen receptors, do influence uterine function in a 
way that remains to be elucidated [2.37]. Interestingly, conceptus estrogens do not appear 
to regulate luteal maintenance in mares [2.38]. Additionally, it has been described that the 
Day 7 equine conceptus expresses mRNA for both intracellular progesterone receptors 
and membrane bound progesterone receptors [2.39]. It has been hypothesized that the 
reproductive steroids may exert their effects on the preimplantation equine conceptus 
directly, and not only via the endometrium [2.39]. The purpose of this study was to 
evaluate Day 8 embryos developed in a progesterone-deprived environment. Embryos 
collected in this study were collected on Day 8, the day of yolk sac completion and prior 
to the synthesis of significant levels of estrogens. Without a properly progesterone 
primed uterus secreting histotroph to provide adequate nutrients for the conceptus to 
develop and begin to secrete its own proteins and steroids, the events of MRP will likely 
be impaired [2.40]. Therefore, this model provides insight into the detrimental effects of 
hypoluteoidism on the endometrium and conceptus during the pre-implantation and MRP 
period in the horse. This novel in vivo model inducing progesterone deprivation during 
diestrus in the mare may offer the ability to further evaluate the direct effects of 




 There is strong evidence to support a crucial role for progesterone in regulating 
early pregnancy events in the horse, including embryo development. The role of 
progesterone in the establishment of pregnancy in the mare is well described, but the 
specifics effects of progesterone deprivation on preimplantation embryo development 
have not been investigated. In this study, we highlight a novel in vivo approach to 
produce embryos in a progesterone-deprived environment (AL cycles) induced by serial 
administration of PGF2α at ovulation. In all AL cycles the mean concentrations of plasma 
progesterone were < 1.0 ng/mL from ovulation (Day 0) until embryo collection (Day 8). 
The embryo quality was adversely affected and stage of development was retarded during 
the AL cycles. The production of aluteal embryos may serve as a novel in vivo model to 
investigate the direct and lasting effects of progesterone on preimplantation equine 
conceptuses. Further investigation applying this model can be utilized to investigate 
embryo-maternal interactions in the mare, especially those mediated directly or indirectly 
by luteal progesterone.  
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CHAPTER 3: EMBRYOS AND ENDOMETRIUM COLLECTED ON DAY 8 OF 




 Aluteal cycles were induced in the mare to evaluate the effects of progesterone 
deprivation on the gene expression of embryos and endometrium collected eight days 
after ovulation. We hypothesized that the transcript expression would be altered during 
induced aluteal cycles (AL) (low progesterone <1 ng/mL) when compared to control 
cycles during diestrus (high progesterone; > 4 ng/mL) for 1) the embryonic expression of 
progesterone mediated transcripts and those related to normal embryo growth and 
development and 2) the endometrial expression of progesterone mediated transcripts and 
those related to prostaglandin synthesis and normal pregnancy establishment. Seven 
cyclic mares with a median age of 6.5 years (range 3-16) were utilized in a crossover 
design. Mares in estrus were artificially inseminated to a fertile stallion and randomly 
assigned to control or AL groups. Mares received either saline solution (control mares) or 
PGF2α (AL mares), twice daily on days 0, 1, and 2 and once daily on days 3 and 4. Serial 
blood samples were collected daily from Day 0 (ovulation) until the day of embryo 
collection and endometrial biopsy on Day 8. Mares were monitored until they returned to 
estrus and were artificially inseminated. Mares were switched to the opposite treatment 
group only after a successful embryo collection occurred during the previous cycle and 
only cycles that produced embryos were used for analyses. The study design resulted in 
paired samples from each mare for analyses. No significant rise in progesterone was 
observed in the AL group with mean concentrations of plasma progesterone remaining < 
1.0 ng/mL from ovulation until embryo collection on Day 8. This is in sharp contrast to 
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the control (luteal) cycle where a post-ovulatory rise in plasma progesterone was 
observed. Real-time RT-PCR was utilized to evaluate the expression of ESR1, PGR, 
CYP19A1, P19, SLC35A1, OCD, APOB, AQP3, NEU2 transcripts in the embryos and 
PTGS2, P19, ESR1, HK2, sPLA2, PGR, CTGF, IFNE, FGF9, SLC36A2 expression in the 
endometrium. Four transcripts showed increased expressed in embryos developed during 
AL cycles ESR1, P19, APOB and PGR (p<0.05). Four transcripts showed increased 
expressed in endometrium developed during AL cycles sPLA2, PGR, ESR1, FGF9 
(p<0.05) and four transcripts showed decreased expression P19, CTGF, IFNE, HK2 
(p<0.05). Additionally, staining differences were present in endometrial staining for both 
ERα and PR receptor during AL cycles compared to control cycles. Embryos and 
endometrium developed in a progesterone-deprived environment during induced aluteal 
cycles demonstrated altered transcript expression. These results indicate that adequate 
progesterone levels may be a key mediator of the appropriate embryo-maternal 
environment during early preimplantation embryo development. 
Keywords: equine, PGF2α, embryo, endometrium, progesterone, transcript 
3.2 Introduction 
 A widely accepted principle of mammalian reproduction is that pregnancy cannot 
occur without progesterone [3.1]. In the mare, the first one third of gestation relies on 
progesterone secreted by the corpora lutea on the equine ovaries [3.1]. After ovulation, 
progesterone concentrations rise sharply in the mare and reach peak values of 12-20 
ng/mL between Days 5 to 10 after ovulation [3.1]. The primary CL remains the only 
source of progesterone for pregnancy support during the first 40 days of gestation, but 
plasma concentrations begin to decline around Day 20 [3.1].  
	 35	
 Early embryonic death (EED) occurs in the mare during the first 40 days of 
pregnancy [3.2]. This time period is divided into two phases, with the first period defined 
as day 0 (fertilization) to 13 and the second period from day 14 to 40 [3.2]. The incidence 
of EED during the first period in young fertile mares is reported to be 9% and can be as 
high as 73% in older mares or those with decreased fertility [3.2]. One of the factors 
involved in early embryonic loss may be hypoleutoidism, insufficiency of the CL, which 
results in low levels of progesterone during early pregnancy [3.1, 3.2]. Progesterone is a 
key modulator ensuring that the appropriate environment is maintained for establishment 
of pregnancy. It ensures uterine quiescence and the production of uterine histotroph, the 
primary conceptus nutrition until placentation [3.3-3.7]. It has been described that 
embryonic loss is more likely to occur when the circulating progesterone concentration is 
< 2 ng/ml compared to increased embryonic survival associated with progesterone 
concentrations > 4 ng/ml [3.8]. 
 The preimplantation period is an essential period for the preparation of both the 
uterus and embryo for the establishment of pregnancy. Recently, transcriptomic studies 
of the equine endometrium have revealed a significant number of genes are differentially 
regulated in pregnant vs. nonpregnant mares between days 8 to 13.5 after ovulation [3.9]. 
Recently, several transcripts have been identified as developmentally important in the 
equine blastocyst [3.10]. Furthermore, several genes expressed in the preimplantation 
equine conceptus have been found to be upregulated during the course of normal 
pregnancy [3.11]. Some of these genes such as apolipoprotein B-100, clone CH241-
268N6 and Fibrinogen beta chain precursor have been found to increase over 100 fold 
from Day 8 to Day 14 in equine conceptuses [3.11]. The preimplantation period marks a 
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critical window in which the developing embryo responds to the maternal environment 
by permanently modifying its epigenome [3.12]. The time period of early embryogenesis 
represents a window where the embryonic genome is exquisitely sensitive to 
disadvantageous developmental programming. This period of sensitivity appears to be 
concentrated into very early development in mammals, up to the blastocyst stage in mice 
and sheep [3.12]. 
 It has recently been demonstrated that the equine preimplantation embryo 
expresses membrane bound steroid hormone receptors that exert their effects via non-
genomic pathways [2.13]. Furthermore, it was elucidated that the equine embryo 
expresses progesterone receptors as early as Day 7 and the level of expression increases 
significantly between Days 7 and 10 [13]. Previous work in our laboratory has 
demonstrated that progesterone-deprivation during the early preimplantation period can 
dramatically affect the morphology of equine embryos collected on Day 8 [2.14]. 
However, the lasting effects of progesterone-deprivation on these embryos and their 
potential for pregnancy establishment have yet to be ascertained. One study evaluated the 
developing equine pregnancy during hypoluteal conditions by administration of PGF2α 
on either Days 12, 14, 16, or 18 post-ovulation [2.15]. Our laboratory has developed a 
novel in vivo model to investigate the effects of progesterone-deprivation during the early 
preimplantation period in the mare. In this model serial administration of PGF2α begins 
within 12 hours post-ovulation (Day 0), then is administered twice daily on Days 0, 1, 
and 2 and then once daily on Days 3 and 4 [2.14, 2.16]. Mares treated according to this 
protocol consistently had mean concentrations of plasma progesterone < 1.0 ng/mL 
throughout (and after) the study period of Days 0–5 and Days 0-8 post-ovulation [2.14, 
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2.16]. The application of this model consisting of 8 serial doses of PGF2α beginning 
immediately post-ovulation reliably prevents normal luteal function in the mare [2.14, 
2.16].  
 The present study was developed utilizing our in vivo model to investigate the 
effects of progesterone-deprivation on the gene expression of preimplantation embryos 
and endometrium recovered from induced aluteal cycles in the mare. We hypothesized 
that the transcript expression would be altered during induced aluteal cycles (AL) (low 
progesterone <1 ng/mL) when compared to control cycles of normal diestrus (high 
progesterone;  > 4 ng/mL) for 1) the embryonic expression of progesterone mediated 
transcripts as well as those related to normal embryo growth and development and 2) the 
endometrial expression of progesterone mediated transcripts as well as those related to 
prostaglandin synthesis and normal pregnancy establishment. 
3.3 Materials and Methods 
3.3.1 Animals and Sample Collection 
The Institutional Animal Care and Use Committee of Louisiana State University 
School of Veterinary Medicine approved all experimental protocols. The work was 
performed in a USDA-registered National Institute of Health-assured, and AAALAC 
International accredited animal facility in accordance with The Guide for the Care and 
Use of Laboratory Animals [2.17]. Seven cyclic Thoroughbred mares with a median age 
of 6.5 years (range 3-16) were utilized in a balanced crossover design from March to 
September 2016 in Baton Rouge, LA. Mares were randomly assigned to one of two 
treatment groups: control (normal diestrus) or induced aluteal (AL). Mares remained in 
the first treatment group assigned to until a positive embryo collection. Immediately after 
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the first positive embryo collection, they were assigned to the opposite treatment group 
and remained in that treatment group until a positive embryo collection. This study 
design resulted in the production of paired samples from control and AL cycles from the 
same mare for analyses. 
Mares were monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm, 
Bothell, WA) throughout the study period. Mares in estrus, as determined by the presence 
of uterine edema and a follicle > 35 mm diameter, were treated once with human 
chorionic gonadotropin (hCG, 2000 IU, IV, Chorulon, Merck Animal Health, 
Kenilworth, NJ). Mares were artificially inseminated every other day until ovulation was 
detected with ≥ 1 x 109 total motile spermatozoa from one stallion of known fertility. 
Reproductive examinations by ultrasonography were performed twice daily after 
insemination until detection of ovulation. After ovulation, mares were randomly assigned 
to one of two treatment groups: control (normal diestrus) or induced aluteal (AL). The 
AL mares were treated according to a protocol previously described [2.14]. Briefly, 
mares were treated twice daily with PGF2α (10 mg, IM, Lutalyse, dinoprost 
tromethamine, Zoetis, Florham Park, NJ) on days 0, 1, and 2, and once daily on days 3 
and 4 [2.14]. The control group was treated on the same schedule with saline solution (2 
mL, IM).  
Embryo collections were performed on Day 8 post-ovulation. Embryos were 
collected in an aseptic manner using Lactated Ringers Solution (LRS) with no 
supplementation (MWI Veterinary Supply, Boise, ID). The uterus was lavaged with 0.5 
to 1 L of LRS at a time and an average 4 to 6 L of LRS was used in total. Recovered 
embryos were identified using a stereomicroscope (SMZ800, Nikon, Melville, NY).  
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Embryos were washed ten times in lactated Ringers solution and immediately 
placed into 1.5 mL Eppendorf tubes (Fisher Scientific, Hampton, NH) in minimal media 
(2-10 µL) and snap frozen in liquid nitrogen. Samples were stored at -80° C until RNA 
isolation was conducted. Immediately after embryo collection, two endometrial biopsies 
were taken using alligator-jaw forceps. One biopsy sample was immediately placed in a 
1.2 mL cryovial (Nalgene®, VWR, Radnor, PA) and snap frozen in liquid nitrogen. 
These samples were stored at -80° C until RNA isolation was conducted. The other 
biopsy sample was formalin fixed for a minimum of 24 hours. After being formalin fixed 
these samples were embedded in paraffin for histological analysis. 
 Mares were monitored for a return to estrus by ultrasonography every other day 
after embryo collection. When they returned to estrus, mares were artificially inseminated 
and managed as described above. Mares remained in the same treatment group until an 
embryo was successfully collected. Upon returning to estrus after a successful embryo 
collection mares were artificially inseminated and managed as described above and 
assigned to the opposite treatment group. 
 Serial blood samples were collected from Day 0 (ovulation) until 8 days post-
ovulation in both control and AL groups. Ten mL of whole blood was collected in 
vacutainer tubes (BD Vacutainer, Becton, Dickinson and Company, Franklin Lakes, NJ) 
containing lithium heparin with 20-ga 1-in vacutainer needles. Blood samples were 
immediately centrifuged at 3000 x g for 10 minutes. Plasma was harvested and stored at -




3.3.2 Progesterone Assay  
 Concentrations of plasma progesterone were determined by a progesterone 
radioimmunoassay (RIA). A technician blinded to treatment protocols and groups 
performed the progesterone assays using a MP Biomedical double antibody approach as 
previously described [2.18]. Concentrations of plasma progesterone on Days 0 to Day 8 
were analyzed by ANOVA for repeated measures (Sigma Plot V14.0, Systat Software, 
San Jose, CA). Data are expressed as mean ± SEM and considered significant when P ≤ 
0.05.  
3.3.3 Isolation of RNA 
 Endometrial tissue homogenization was carried out individually using a Bullet 
Blender® Gold (Next Advance, Troy, NY) for 5 min at full speed. To perform 
homogenization tissues were placed in 1.5 mL Rino® tubes (RNase free, Next Advance, 
Troy, NY) with 8 stainless steel beads (RNase free, SSB14B, Next Advance, Troy, NY) 
and 500 µL of lysis buffer to achieve a 2:1:1 ratio of lysis buffer to tissue to beads. Total 
cellular RNA was isolated from individual homogenized endometrial samples using the 
Pure Link® RNA Mini Kit (12183018A; Thermo Fisher Scientific, Waltham, MA) 
according to manufacturer’s instructions. Isolated RNA was quantified via 
spectrophotometry using a NanoDrop One™ (Thermo Fisher Scientific, Waltham, MA) 
and analyzed for quality by determining RNA integrity number (RIN) using a Fragment 
Analyzer™ Automated CE System (Advanced Analytial Technologies, Inc., Ankeny, 
IA). Samples with a RIN of ≥ 6.8 were used for analysis and 12 samples had a RIN of > 
8. 
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 Total cellular RNA was isolated from individual Day 8 embryos using the 
PicoPure™ RNA Isolation Kit (KIT0202, Thermo Fisher Scientific, Waltham, MA) 
according to the manufacturer’s instructions. Isolated RNA was quantified via 
spectrophotometry using a NanoDrop One (Thermo Fisher Scientific, Waltham, MA) and 
analyzed for quality by determining RNA integrity number (RIN) using a Fragment 
Analyzer™ Automated CE System (Advanced Analytical Technologies, Inc., Ankeny, 
IA). Samples with a RIN of > 8 were used for analysis. 
3.3.4 Real Time RT-PCR 
  For individual embryo and endometrial samples, cDNA was synthesized using 
the SuperScript™ IV VILO™ Master Mix (Thermo Fisher Scientific, Thermo Fisher 
Scientific, Waltham, MA). Ten transcripts were chosen for evaluation in the Day 8 
endometrium; prostaglandin-endoperoxide synthase 2 [PTGS2], P19 lipocalin [P19], 
progesterone receptor [PGR], estrogen receptor [ESR1], hexokinase 2 [HK2], 
phospholipase A2 [sPLA2], connective tissue growth factor [CTGF], interferon epsilon 
[IFNE], fibroblast growth factor 9 [FGF9], and solute carrier family 36 member A2 
[SLC36A2]. Nine transcripts were chosen for evaluation in the Day 8 embryos; ESR1, 
PGR, aromatase [CYP19A1], P19, solute carrier family 35 member A1 [SLC35A1], 
ornithine decarboxylase 1 [ODC1], apolipoprotein B [APOB], aquaporin 3 [AQP3], and 
neuraminidase 2 [NEU2]. These transcripts were selected due to their involvement in 
steroidogenesis, embryo growth and development, and the establishment of normal 
pregnancy under luteal conditions. Primers were designed using Primer-BLAST 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/), all products were less than 180 bp 
and are listed in Table 3.1. Primer specificity was confirmed through sequencing of the  
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Table 3.1 List of primers used in real-time RT PCR 
 
 
resulting products. All PCR reactions were carried out in duplicate using Power™ 
SYBR™ Green Master Mix (Thermo Fisher Scientific, Thermo Fisher Scientific, 
Waltham, MA) with a total volume of 10 µl containing 200nM of forward and reverse 





































































primer and 1 µl of cDNA. A no-template control and no reverse transcriptase control 
(NRT) were included. Resulting Cq values were normalized for the housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to obtain ΔCq values. The ΔΔCq 
method was used to calculate fold changes between treated and control samples. 
Normality of data was confirmed, and ΔCq values were analyzed using a paired t-test 
(Sigma Plot V14.0, Systat Software, San Jose, CA). Results were considered significant 
when P ≤ 0.05.  
3.3.5 Immunohistochemistry 
 The formalin fixed specimens were processed, embedded and sectioned by 
routine histological methods. Sections from each specimen were examined by a board 
certified veterinary pathologist to define locations within the endometrium that contained 
representative areas of superficial surface epithelium and glands of the stratum 
compactum. These areas were marked on each slide. From the corresponding area on the 
original blocks, 2 tissue cylinders of 1-mm diameter were cored using a manual tissue 
microarrayer. The cores were arranged in the new microarray block at an approximate 
distance of 4 mm between each core. The top right corner of each microarray was left 
blank to mark the proper orientation.  
 Tissue Micro Array (TMA) sections were submitted for immunohistochemical 
staining for progesterone and estrogen receptor expression. TMA sections were 
deparaffinized in xylene and rehydrated in graded alcohol. Antigen retrieval was 
performed by incubation in target retrieval solution (DAKO, Santa Clara, CA) at 125°C. 
The sections were incubated in 3% hydrogen peroxide in methanol, then blocked in a 
serum-free protein block (DAKO, Santa Clara, CA). The sections were then incubated 
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with anti-mouse primary antibodies for progesterone and estrogen receptors (PgR ab-8, 
prediluted, MS-298-R-7-A and ERα, 1:500 dilution, PA5-16440, ThermoFisher 
Scientific, Grand Island, NY). Optimal dilution was determined by titration on whole 
sections of equine control endometrial tissue. The sections were incubated with a 
biotinylated horse anti-mouse secondary antibody (1:200 dilution) for 30 minutes (Vector 
Laboratories, Burlingame, CA). Subsequently, the sections were incubated for 30 minutes 
with Vector RTU ABC Elite (Vector Laboratories, Burlingame, CA), followed by 
incubation with DAB+ chromogen (DAKO). Each incubation step was followed by rinse 
steps in Tris Buffered Saline (TBS) buffer. All sections were counterstained with 
hematoxylin.  
 Each TMA was scanned utilizing the Aperio slide scanning system (Leica 
Biosystems, Buffalo Grove, IL) at 40X magnification. Following the scanning procedure, 
region selection and staining intensity analysis was performed utilizing Aperio 
ImageScope software (Leica Biosystems, Buffalo Grove, IL). The free form pen tool was 
used to select three non-continuous areas of luminal endometrial epithelium (LE) and 
endometrial glands (GE) in each core. This resulted in 6 total areas of analysis for both 
LE and GE for each animal. Image analysis was performed using a Positive Pixel Count 
v9.1 algorithm with the following thresholds [Hue Value =.1; Hue Width =.5; Color 
Saturation Threshold =0.04; IWP(High) = 220; Iwp(Low)=Ip(High) = 175; Ip(low) 
=Isp(High)=100 Isp(Low) =0]. The percent positive pixels in a region was determined by 
adding the number of positive pixels (Np) to the number of strong positive pixels (Nsp) 
divided by the total number of negative and positive pixels (NTotal). The average 
staining intensity was determined by adding the total intensity of positive pixels (Ip) and 
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the total intensity of strong positive pixels (Isp) divided by the sum of the number of 
positive pixels (Np) and the number of strongly positive pixels (Nsp).  
 Normality of data was assessed, and percent positive pixels and average staining 
intensity were analyzed using a paired t test (Sigma Plot V14.0, Systat Software, San 
Jose, CA). Results were considered significant when p ≤ 0.05 and data are expressed as 
mean ± SEM. 
3.4 Results 
3.4.1 Progesterone Assay 
 The plasma progesterone profiles differed significantly between the control and 
AL groups. The mean daily concentration of plasma progesterone remained < 1.0 ng/mL 
throughout the study period (Day 0 to 8) in the AL group (Fig. 3.1). This is compared to 
the control group where a typical diestrus rise was observed and plasma progesterone 
peaked at > 9 ng/mL (Fig. 3.1). A significant difference was observed between the AL 
and control group beginning on Day 3 (p < 0.001) (Fig. 3.1). However, it is important to 
note that beginning on Day 2 concentrations of plasma progesterone had already risen to 
> 2.0 ng/mL in the control group compared to 0.7 ng/mL in the AL group (Fig. 3.1). 
3.4.2 Real Time RT-PCR 
 Evaluation utilizing real-time RT PCR demonstrated altered transcript expression 
when Day 8 embryos and endometrium are developed in a progesterone-deprived 
environment (< 1.0 ng/mL) during induced aluteal cycles. Eight out of the ten transcripts 
evaluated in the endometrium were differentially expressed in AL cycles compared to 
controls (Fig. 3.2). Four transcripts showed increased expression in endometrium  
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Fig. 3.1. Mean (± S.E.M.) daily concentrations of plasma progesterone in control and 
induced aluteal treatment groups. During the induced aluteal cycles the mean daily 
concentrations of plasma progesterone remained < 1.0 ng/mL. This is in contrast to the 
control (luteal) cycle where a post-ovulatory rise in progesterone was observed. The 
mean daily concentrations of plasma progesterone differed significantly in control vs. 
aluteal group beginning at Day 3 until the end of the study period (Day 8) (*; p < 0.001) 
developed during AL cycles compared to control cycles; sPLA2, PGR, ESR1, FGF9 with  
 
a 3.0, 2.5, 1.2, and 6.3-fold increase, respectively (p < 0.05) (Fig. 3.2). Additionally, P19, 
CTGF, IFNE, HK2, showed decreased endometrial expression when developed during 
AL cycles with a 0.03, 0.13, 0.12, and 0.14-fold decrease respectively (p < 0.05) (Fig. 
3.2). Four genes were significantly upregulated out of the nine genes evaluated in Day 8 
AL vs. control embryos (Fig. 3.3). In the Day 8 AL embryos ESR1, P19, APOB, and 
PGR exhibited a 1483.9, 93.2, 29.3, and 12.33-fold increase respectively (p < 0.05) (Fig. 




Fig. 3.2. Transcript expression in Day 8 control vs. induced aluteal endometrium. Eight 
out of ten transcripts evaluated were differentially expressed in the endometrium of 
induced aluteal mares vs. control. (*; p < 0.05) 
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Fig 3.3. Transcript expression of Day 8 control vs. induced aluteal embryos. Four of the 
genes evaluated, ESR1, PGR, P19 and APOB, were significantly upregulated in induced 
aluteal embryos vs. control (*; p < 0.05). 
 
3.4.3 Immunohistochemistry 
 The quantitative evaluation of Day 8 endometrium showed differences in both 
ERα and PR staining (Table 3.2). No difference was observed in ERα protein expression 
by percent positive pixels or average staining intensity in the LE. Conversely, in the GE, 
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a significant difference was observed in the average staining intensity of ERα protein (p < 
0.005) (Table 3.2, Fig. 3.4). The average staining intensity of ERα in the control GE was 
76.98 ± 2.15 compared to 59.94 ± 2.33 in the AL group (p < 0.005) (Table 3.2, Fig. 3.4). 
A significant difference was observed between the control and AL groups in both the 
percent positive pixels and average staining intensity of the PR in the LE (p < 0.05) 
(Table 3.2, Fig. 3.5). There was an increase in percent positive pixels in AL compared to 
control endometrium; 0.422 ± 0.21 vs. 0.234 ± 0.040, respectively (p < 0.05) (Table 3.2, 
Fig. 3.5). Additionally, the AL group demonstrated a decrease in average staining 
intensity, 63.77 ± 7.44 compared to 73.43 ± 8.68 in the control group (p < 0.05) (Table 
3.2, Fig. 3.5). This is compared to the GE where a decrease in the percent positive pixels 
of the PR was observed in control vs. AL, 0.425 ± 0.017 vs. 0.634 ± 0.033, respectively 
(p < 0.001) (Table 3.2, Fig. 3.5). However, no difference was present in the average 
staining intensity of PR in the GE (p > 0.05) (Table 3.2, Fig 3.5).   
 
Table 3.2 Immunohistochemical expression of progesterone receptor (PR) and estrogen 
receptor alpha (ERα) in the luminal (LE) and glandular epithelium (GE) 
 
a,b; p < 0.05 
 
3.5 Discussion 
 The present study utilized induced aluteal cycles in the mare to evaluate the 
effects of progesterone-deprivation on the gene expression in Day 8 embryo and 
 
Control AL Control AL
PR LE 0.76 ± 0.03 0.75 ± 0.08 89.83 ± 3.72 79.77 ± 4.28
PR GE 0.88 ± 0.02 0.90 ± 0.02 76.98 ± 2.15a 59.94 ± 2.33b
ERα LE 0.23 ± 0.02a 0.42 ± 0.02b 73.43 ± 8.68a 63.77 ± 7.44b 
ERα GE 0.43 ± 0.02a 0.63 ± 0.03b 57.94 ± 2.90 60.21 ± 1.94

















Fig. 3.4. Sections from Day 8 endometrium stained with anti-mouse primary antibodies 
for estrogen receptor alpha. Pairs of the same letter indicate the endometrium was 
collected from control and induced aluteal cyles in the same mare. A1) Control cycle; 
A2) Induced aluteal cycle. The negative control is inset in each panel. 
 
endometrium. Progesterone-deprived cycles (< 1.0 ng/mL) were induced in all AL mares 
throughout the study duration by administration of serial doses of PGF2α beginning 
within 12 hours of ovulation. The concentration of progesterone differed significantly 
from that of control cycles, which displayed a typical diestrus rise. This altered hormonal 




















Fig. 3.5. Sections from Day 8 endometrium stained with anti-mouse primary antibodies 
for progesterone receptor. Pairs of the same letter indicate the endometrium was collected 
from control and induced aluteal cycles in the same mare. A1) Control cycle; A2) 
Induced aluteal cycle.  The negative control is inset in each panel. 
 
Day 8 embryo and endometrium. Additionally, the endometrial expression of PR and 
ERα protein differed in treatment mares. 
 Plasma progesterone remained < 1.0 ng/mL throughout the duration of the study 
in all treatment mares. A previously validated model utilizing eight serial injections of 






treatment mares [3.14, 3.16]. This resulted in a progesterone-deprived in vivo 
environment during the early preimplantation period (Days 0 to 8), which was 
significantly different than control cycles with elevated plasma progesterone consistent 
with diestrus and early pregnancy. Progesterone is essential for appropriate embryo 
development during the early preimplantation period in mammals. It has been 
demonstrated in the cow and mare that progesterone concentrations are significantly 
higher in the oviduct ipsilateral to the ovary with a functioning CL during diestrus and 
early pregnancy [3.19, 3.20]. Furthermore, it has been demonstrated both in vitro and in 
vivo that the presence of progesterone can have rapid effects on ciliary beat frequency in 
the oviducts of humans, mice, cattle, and the guinea pig [3.21-3.24]. The ciliary beat 
frequency functions in transport of tubal stage embryos [3.22]. The effects of 
progesterone on the oviductal environment and embryo transport is especially important 
in the horse where embryo transport through the oviduct lasts 6 days [3.25]. Progesterone 
also plays an important role in the preparation of the uterus and endometrium for the 
establishment of pregnancy. Endometrial hypertrophy occurs during diestrus and 
increases with embryo implantation during pregnancy [3.26, 3.27]. Concurrent with 
endometrial hypertrophy, endometrial gland density increases and is directly related to 
successful pregnancy outcome in mares [3.28]. These endometrial glands synthesize and 
secrete uterine proteins and related substances, which comprise the histotroph, the 
primary conceptus nutrition until attachment and placentation [3.29]. The altered 
hormonal milieu present in AL cycles likely results in unfavorable effects on both the 
embryo and endometrium for the establishment of pregnancy. 
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 Four transcripts were significantly higher expressed in embryos collected from 
AL cycles. These transcripts ESR1, P19, APOB and PGR are related to hormone 
signaling, embryonic capsule formation and nutrient transport. The increase in ESR1 
transcript, which codes for ERα, is likely due to the lack of progesterone during the AL 
cycles. It has been demonstrated that the expression of ERα is increased during estrus and 
decreased during pregnancy in the endometrium of mares [3.30]. The hormonal milieu of 
AL cycles mimics a mare in estrus with low progesterone versus the progesterone-
dominated phase of early pregnancy. One of the most abundant proteins of the equine 
uterine histotroph is P19, a progesterone mediated lipocalin important in the assembly of 
the embryonic capsule [3.31]. One study has elucidated that the expression of P19 is 
highest in Day 8 equine conceptus and expression decreases from Day 10 to 14 [3.11]. In 
that study, the decreased embryonic P19 transcript expression from Day 10 to 14 was 
contributed to the high amounts of P19 supplied to the conceptus of uterine origin [3.11]. 
The increased expression of P19 in AL embryos may be due the low progesterone 
concentrations resulting in a lack of uterine P19 supplied to the conceptus. 
Apolipoproteins are proteins that play an essential role in the transport of lipids by 
binding lipids to form lipoproteins [3.11]. Embryos recovered from AL cycles are 
developmentally delayed compared to Day 8 embryos recovered from a typical diestrus 
mare [3.14]. It has been suggested that in the developing equine embryo, similar to the 
mouse, APOB may play a role in the transport of lipids via yolk sac mediated synthesis 
and secretion of lipoproteins [3.11, 3.32]. This increased expression of APOB may be 
attempting to compensate for nutrient deficiencies occurring in a progesterone-deprived 
environment. The Day 7 equine embryo expresses mRNA for both genomic and non-
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genomic progesterone receptors [3.13]. As a result, it has been hypothesized that 
reproductive steroids, specifically estrogen and progesterone, may directly affect the 
preimplantation equine conceptus and not only act via the endometrium [3.13]. Our 
results demonstrating upregulation of PGR transcripts during induced AL cycles supports 
this hypothesis. 
 The expression of eight out of ten endometrial transcripts evaluated was altered in 
AL mares. Three of the four transcripts demonstrating an increased expression; sPLA2, 
PGR, ESR1, are progesterone mediated [3.30, 3.33, 3.34]. The PLA2 family is the rate-
limiting enzyme in the biosynthesis of prostaglandins, and sPLA2 is directly involved in 
the synthesis of PGF2α [3.33, 3.35]. A negative correlation exists between PLA2 
expression and progesterone levels, which indicates that progesterone controls the 
expression levels of the PLA2 family [3.33]. The increased expression of sPLA2 during 
AL cycles relates to the negative association of progesterone levels and this transcript. 
The ESR1 transcript is a steroid hormone receptor, which codes for ERα protein, and is 
involved in uterine development and steroid hormone activity [3.35]. In the mare, 
concentrations of ESR1 are highest during estrus and early diestrus, which correspond to 
low levels of progesterone as seen in the AL mares [3.34]. The PGR transcript is 
progesterone-mediated and constant exposure to progesterone can cause a down 
regulation of transcript expression. Expression of PGR is higher during estrus than during 
pregnancy in the mare [3.30]. The expression pattern of both ESR1 and PGR in the AL 
endometrium parallels the increased expression of these transcripts during estrus with 
low progesterone concentrations. It has been postulated that steroid hormones may drive 
regulation of the fourth transcript, FGF9. In the mare, the expression of FGF9 is 
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upregulated on Day 12 in pregnant endometrium and this increased expression occurs 
shortly after the equine embryo begins to secrete significant amounts of estrogens [3.9, 
3.36, 3.37]. The expression pattern of FGF9 is complex, and upregulation of this gene 
corresponds to estrogen signaling in the pregnant endometrium of the pig, human and 
mare [3.9, 3.38-3.40]. This suggests that the expression of FGF9 may also have a 
negative correlation with progesterone levels, which may explain the increased 
expression of FGF9 in the progesterone-deprived AL cycles. 
 Four transcripts displayed a decreased expression in the endometrium of AL 
mares. The expression of two of these transcripts, HK2 and P19 has been demonstrated to 
be progesterone mediated [3.41, 3.32]. Glycogen, the main storage form of glucose in the 
body, is a component of the endometrial histotroph and HK2 plays a role in glycogen 
synthesis by converting glucose into glucose-6-phosphate [3.41, 3.42]. The transcript 
abundance of HK2 is significantly higher during diestrus and pregnancy than during 
estrus or anestrus in the mare [3.41]. Thus the expression of HK2 is significantly greater 
during the progesterone-dominated phase of the estrous cycle [3.41]. As previously 
discussed, P19 is one of the most abundant constituents of equine histotroph and plays a 
role in the establishment of the embryonic capsule [3.31]. When evaluating the presence 
of immunoreactive P19, it is present in large amounts during diestrus and early pregnancy 
and barely detectable in the endometrium of mares in estrus [3.43]. P19 is present in 
moderate amounts in the Day 8 conceptus and expression decreases from Day 10 to Day 
14 due to the high amounts of uterine P19 supplied to the conceptus [3.11]. The 
expression of P19 is progesterone mediated, and the decreased expression of P19 in the 
progesterone-deprived cycles of AL mares agrees with previous reports describing a lack 
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of P19 expression when progesterone concentrations are low such as during estrus. Type 
1 interferons (IFNs) are a family of cytokines with antiviral activity [3.44]. Unlike other 
IFNs the expression of IFNE is not regulated by viral infection [3.44]. In humans and 
mice, the female reproductive tract constitutively expresses IFNE, and expression is 
hormonally driven in both species with highest expression during the estrogen dominated 
proliferative phase [3.44, 3.45]. Conversely, the equine endometrium expresses higher 
levels of IFNE during the progesterone dominated phases of diestrus and pregnancy 
compared to estrus [Klein C., unpublished data]. Furthermore, progesterone receptor 
binding sites have been identified in the promotors of both mouse and human IFNE genes 
[46]. Due to the unique hormonal regulation of this transcript, it is likely that the 
decreased expression of IFNE in the endometrium of AL mares is a result of the 
progesterone-deprivation during these cycles. Connective tissue growth factor is a 
transcript that has been associated with endometrial cell proliferation, differentiation and 
angiogenesis during early pregnancy in the mouse and mare [3.47, 3.48]. One study 
demonstrated that CTGF was expressed at high levels in Day 16 pregnant mare 
endometrium [3.47]. It is speculated that reciprocal signaling of CTGF and additional 
growth factors between the conceptus and endometrium assist in the maintenance of early 
pregnancy in the mare [3.47]. It has been described that embryos collected from AL 
cycles are developmentally delayed according to diameter, morphology and quality grade 
[3.14]. The resulting improperly primed endometrium and developmentally affected 
embryos produced during AL cycles likely affected the signaling events required for 
appropriate expression of CTGF.  
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 In the present study, the percent positive pixels of PR in both the LE and GE were 
significantly increased in the AL mares. Our findings correspond with reports citing lack 
of localization of PR on the LE and GE in pregnant mares [3.49]. During early pregnancy 
PR are present at Day 10 and with continuous exposure to progesterone, these receptors 
are down regulated [3.49]. Additionally, it has been described that expression level of PR 
is greater during estrus than pregnancy in the mare [3.30]. The increase in percent 
positive pixels of PR in AL mares likely corresponds to the lack of progesterone resulting 
in an environment that mimics estrus. Additionally, this finding correlates with the 
increased expression of the PGR transcript in the endometrium of AL mares. The 
increased transcript expression likely resulted in an increase in translation and receptor 
expression in treated mares. Interestingly, the average staining intensity of PR in the LE 
was significantly lower in the AL endometrium. Average staining intensity reflects the 
concentration of PR in a given location. This reduced average staining intensity of PR in 
AL mares compared to the increased transcript expression of PGR may be due to the 
differential localization of PR within the nucleus and cytoplasm in the LE. In the present 
study the PR staining was subjectively localized predominantly to the nuclei of the 
epithelial cells rather than their cytoplasm. Several reports have described the localization 
of PR to the nuclei of the epithelial cells rather than their cytoplasm in the mare [3.30, 
3.49]. The only difference noted in the expression of ERα was a decrease in average 
staining intensity in AL mares compared to control mares. However, it has previously 
been reported that immunolabeling of ERα is more intense during estrus than pregnancy 
[3.30]. The present results are the opposite of what would be expected with less intense 
ERα staining appearing in the progesterone-deprived endometrium. The decrease in the 
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average staining intensity of the ERα may be due to the localization of receptor in the 
GE. The localization of the ERα was similar to that of the PR with expression 
predominantly localized subjectively to the nuclei versus the cytoplasm. It has previously 
been reported that ERα is localized predominantly to the cytoplasm rather than the nuclei 
of the epithelial cells in the mare [3.49]. However, the variability in the staining pattern 
of ERα seen in this study compared to other studies may be due to differences in the 
primary antibody used. Interestingly, the decreased staining intensity of ERα in AL 
endometrium conflicts with the increased transcript expression of ESR1 in AL 
endometrium. However, transcript expression only partially explains protein expression 
and different post-transcriptional regulatory factors regulate mRNA protein expression 
[3.30, 3.50]. The analysis of specific distributions of PR and ERα are not within the scope 
of this study. 
3.6 Conclusions 
 In the mare adequate progesterone concentrations are essential for the successful 
establishment of pregnancy. Hypoluteoidism can result in inadequate progesterone 
concentrations incompatible with pregnancy and contribute to EED in the mare. Until 
recently, there was no model available to investigate equine pregnancy in hypoluteal 
conditions. This study utilized a novel in vivo model to induce aluteal cycles and evaluate 
the effects of in vivo progesterone-deprivation on embryos and endometrium. Several of 
the transcripts selected for evaluation were differentially expressed in Day 8 embryos and 
endometrium collected from AL mares. Additionally, the expression of selected steroid 
receptors was altered in the endometrium from AL cycles. The results of this study 
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indicate that adequate progesterone levels during the preimplantation period play an 
important role in regulating embryonic and endometrial gene expression in the mare.  
3.7 References 
[3.1] Allen WR. Luteal deficiency and embryo mortality in the mare. Reprod Domest 
Anim 2001;36:121-31. 
 
[3.2] Ball BA, Little TV, Hillman RB. Pregnancy rates at days 2 and 14 and estimated 
embryonic loss rates prior to day 14 in normal and subfertile mares. Theriogenology 
1986;26:611-19. 
 
[3.3] Aurich C, Budik S. Early pregnancy in the horse revisited – does exception prove 
the rule? J Anim Sci Biotechnol 2015;6(50)1-8. 
 
[3.4] Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of 
birth at term and preterm. Endocr Rev 2000;21:515-50. 
 
[3.5] Holtan DW, Houghton E, Slver M, Fowden AL, Ousey J, Rossdale PD. Plasma 
progesterone in the mare, fetus and newborn foal. J Reprod Fert 1991;44:517-28. 
 
[3.6] Lye SJ, Ou C-W, Teoh T-G, Erb G, Stevens Y, Casper R, Patel FA, Challis JRG. 
The molecular basis of labour and tocolysis. Fetal Maternal Med Rev 1998;10:121-36. 
 
[3.7] Sharp DC. The early fetal life of the equine conceptus. Anim Reprod Science 
2000;60-1:679-89. 
 
[3.8] Ginther OJ. Embryonic loss in mares: incidence, time of occurrence, and hormonal 
involvement. Therio 1985;23:77-89. 
 
[3.9] Merkl M, Ulbrich SE, Otzdorff C, Herbach N, Wanke R, Wolf E, et al. Microarray 
analysis of equine endometrium at day 8 and 12 of pregnancy. Biol Reprod 2010;83:874-
76. 
 
[3.10] Smits K, Goossens K, Van Soom A, Govaere J, Hoogewijs M, Peelman LJ. In 
vivo-derived horse blastocysts show transcriptional upregulation of developmentally 
important genes compared with in vitro-produced horse blastocysts. Reprod Fert 
Development  2011;23:364-75. 
 
[3.11] Klein C, Troedsson MH. Transcriptional profiling of equine conceptuses reveals 
new aspects of embryo-maternal communication in the horse. Biol Reprod 2011;84:872-
5. 
 
[3.12] Sinclair KD, Singh R. Modelling the developmental origins of health and disease 
in the early embryo. Theriogenology 2007;35:43-53. 
	 60	
 
[3.13] Rambags BPB, van Tol HTA, van den Eng MM, Colenbrander B, Stout TAE. 
Expression of progesterone and oestrogen receptors by early intrauterine equine 
conceptuses. Theriogenology 2008;69:366-75. 
 
[3.14] Leisinger CA, Medina V, Markle ML, Paccamonti DL, Pinto CRF. Morphological 
evaluation of Day 8 embryos developed during induced aluteal cycles in the mare. 
Theriogenology 2018;105:178-83. 
 
[3.15] Betteridge KJ, Waelchli RO, Christie HL, Raeside JI, Quinne BA, Hayes MA. 
Relationship between the timing of prostaglandin-induced luteolysis and effects on the 
conceptus during early pregnancy in mares. Reprod Fert Development 2012;24:411-24. 
 
[3.16] Coffman EA, Pinto CR, Snyder HK, Leisinger CA, Cole K, Whisnant CS. 
Antiluteogenic effects of serial prostaglandin F2α administration in cycling mares. 
Theriogenology 2014;82(9):1241-5. 
 
[3.17] Institute for Laboratory Animal Research Council. Guide for the Care and Use of 
Laboratory Animals, 8th ed. Washington (DC): National Academies Press 2011. 
 
[3.18] Pohler, KG, Pereira MHC, Lopes FR, Lawrence JC, Keisler DH, Smith MF, et al. 
Circulating concentrations of bovine pregnancy-associated glycoproteins and late 
embryonic mortality in lactating dairy herds. J Dairy Sci 2016;99:1584-94. 
 
[3.19] Hilde N, Bussche JV, Wojciechowicz B, Franczak A, Vanhaecke L, Leemans B, 
Cornille P, et al. Steroids in the equine oviduct: synthesis, local concentrations and 
receptor expression. Reprod Fert Develop 2016;28:1390-404. 
 
[3.20] Wijayagunawardane MP, Cerbito WA, Miyamoto A, Acosta TJ, Takagi M, 
Miyazawa K, Sato K. Oviductal progesterone concentration and its spatial distribution in 
cyclic and early pregnant cows. Theriogenology 1996;46(7):1149-58. 
 
[3.21] Bylander A, Nutu M, Wellander R, Goksör M, Billig H, Larsson DGJ. Rapid 
effects of progesterone on ciliary beat frequency in the mouse fallopian tube. Reprod Biol 
Endocrinol 2010;8:48. 
 
[3.22] Helm G, Owman C, Sjöberg NO, Walles B. Motor activity of the human Fallopian  
tube in vitro in relation to plasma concentration of oestradiol and progesterone, and the 
influence of noradrenaline. J Reprod Fert 1982;64:233-42.  
 
[3.23] Nakahari T, Nishimura A, Shimamoto C, Sakai A, Kuwabara H, Nakano T, et al. 
The regulation of ciliary beat frequency by ovarian steroids in the guinea pig Fallopian 
tube: interactions between oestradiol and progesterone. Biomed Res 2011;32:321–8. 
 
	 61	
[3.24] Wessel T, Schuchter U, Walt H. Ciliary motility in bovine oviducts for sensing 
rapid non-genomic reactions upon exposure to progesterone. Horm Metab Res 
2004;36:136-41. 
 
[3.25] Allen WR. The physiology of early pregnancy in the mare. AAEP proceedings 
2000;46:338-54. 
 
[3.26] Lefranc, AC, and Allen, WR. Influence of breed and oestrous cycle on endometrial 
gland surface density in the mare. Equine Vet J 2007;39: 506–10. 
 
[27] Lefranc, AC, and Allen, WR. Endometrial gland surface density and hyperaemia of 
the endometrium during early pregnancy in the mare. Equine Vet J 2007;39: 511–5. 
 
[3.28] Michiko H, Yousuke H, Oikawa M. Equine endometrial gland density and 
endometrial thickness vary among sampling sites in Thoroughbred mares. J Equine Sci 
2012;23:35-40. 
 
[3.29] Gray CA, Bartol FF, Tarleton BJ, Wiley AA, Johnson GA, Bazer FW, Spencer TE. 
Developmental biology of uterine glands. Biol Reprod 2001;65:1311-23. 
 
[3.30] Silva ESM, Scoggin KE, Canisso IF, Troedsson MHT, Squires EL, Ball BA. 
Expression of receptors for ovarian steroids and prostaglandin E2 in the endometrium and 
myometrium of mares during estrus, diestrus and early pregnancy. Animal Reprod Sci 
2014;151;169-81. 
 
[3.31] Stewart F, Charleston B, Crossett B, Barker PJ, Allen WR. A novel uterine protein 
that associates with the embryonic capsule in equids. J Reprod Fertil 1995; 105:65–70. 
 
[3.32] Farese RV Jr, Cases S, Ruland SL, Kayden HJ, Wong JS, Young SG, Hamilton 
RL. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical 
for maternal-fetal lipid transport in mice. J Lipid Res 1996;37:347–60. 
 
[3.33] Ababneh M, Ababneh H, Shidaifat, F. Expression of cytosolic phospholipase A2 
in equine endometrium during the oestrous cycle and early pregnancy. Reprod Domest 
Anim 2011;46:268–74. 
 
[3.34] Hartt, LS, Carling SJ, Joyce MM, Johnson GA, Vanderwall DK, Ott TL. Temporal 
and spatial associations of oestrogen receptor alpha and progesterone receptor in the 
endometrium of cyclic and early pregnant mares. Reprod 2005;130:241–50.  
 
[3.35] Klohonatz KM, Hess AM, Hansen TR, Squires EL, Bouma GJ, Bruemmer JE. 
Equine endometrial gene expression changes during and after maternal recognition of 
pregnancy. J Anim Sci 2015;93:3364-76. 
 
	 62	
[3.36] Paulo E and Tischner M. Activity of Δ53β-hydroxysteroid Dehydrogenase and 
steroid hormones content in early preimplantation horse embryos. Folia Histochim 
Cytobiol 1985;23:81-4. 
 
[3.37] Raeside JI, Christie HL, Renaud RL, Waelchli RO, Betteridge. Estrogen 
metabolism in the equine conceptus and endometrium during early pregnancy in relation 
to estrogen concentrations in yolk-sac fluid. Biol Reprod 2004;71:1120-7. 
 
[3.38] Chuang PC, Sun HS, Chen TM, Tsai SJ. Prostaglandin E2 induces fibroblast 
growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling. Mol Cell 
Biol 2006;26:8281–92. 
 
[3.39] Ostrup E, Bauersachs S, Blum H, Wolf E, Hyttel P. Differential endometrial gene 
expression in pregnant and nonpregnant sows. Biol Reprod 2010;83:277–85. 
 
[3.40] Tsai SJ, Wu MH, Chen HM, Chuang PC, Wing LY. Fibroblast growth factor-9 is 
an endometrial stromal growth factor. Endocrinology 2002;143:2715–21. 
 
[3.41] Bramer SA, Macedo A, Klein C. Hexokinase 2 drives glycogen accumulation in 
equine endometrium at day 12 of diestrus and pregnancy. Reprod Biol Endocrinol 
2017;15:1-7. 
 
[3.42] Freeman KP, Roszel JF, Slusher SH, Castro M. Variation in glycogen and 
mucins in the equine uterus related to physiologic and pathologic conditions. 
Theriogenology. 1990;33(4):799–808. 
 
[3.43] Stewart F, Gerstenberg C, Suire S, Allen WR. Immunolocalization of a novel 
protein (P19) in the endometrium of fertile and subfertile mares. J Reprod Fertil 
2000;(56):593-9. 
 
[3.44] Fung KY, Mangan NE, Cumming H, Horvat JC, Mayall JR et al. Interferon-
epsilon protects the female reproductive tract from viral and bacterial infection. Science 
339;2013:1088-92. 
 
[3.45] Hermant P, Francius C, Clotman F, Michiels T. INF-ε is constitutively expressed 
by cells of the reproductive tract and is inefficiently secreted by fibroblast and cell lines. 
PLoS ONE 2013;8:1-9.  
 
[3.46] Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ. Characterization 
of the type I interferon locus and identification of novel genes. Genomics 84;2004;331-
45. 
 
[3.47] Klein C. Novel equine conceptus-endometrial interactions on Day 16 of pregnancy 
based on RNA sequencing. Reprod Fert Development 2015;28:1712-20. 
 
	 63	
[3.48] Moussad, E. E., Rageh, M. A., Wilson, A. K., Geisert, R. D., and Brigstock, D. R. 
(2002). Temporal and spatial expression of connective tissue growth factor (CCN2; 
CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero–placental 
interface during early pregnancy in the pig. Mol. Pathol. 55, 186–92. 
 
[3.49] Wilsher S, Gower S, Allen WR. Immunohistochemical localization of 
progesterone and oestrogen receptors at the placental interface in mares during early 
pregnancy. Animal Reproduction Science 2011; 129:200-8. 
 
[3.50] Abreu R de S, Penalva LO, Marcotte EM, Vogel C. Global signatures of protein 
and mRNA expression levels. Mol Biosyst 2009;5(12):1512-26.  
	 64	
CHAPTER 4: PROGESTERONE DEPRIVATION DURING THE 
PERIOVULATORY PERIOD CAUSES DELAYED PREGNANCY 
DEVELOPMENT IN THE MARE 
 
4.1 Summary 
 Serial administrations of PGF2α were utilized to induce aluteal cycles in the mare 
to evaluate the effects of progesterone-deprivation on embryonic vesicle development in 
the mare. We hypothesized that progesterone-deprivation during early embryogenesis 
would result in delayed embryonic vesicle size and retarded growth compared to control 
cycles. Eight cyclic mares with a median age of 8 years (range 4 to 16) were utilized. 
Mares in estrus were artificially inseminated to a fertile stallion and randomly assigned to 
control or induced aluteal rescue (ALR) groups. Mares received either saline solution 
(control) or PGF2α (ALR), once daily on days 0 through 4. Then on Day 5 post ovulation 
mares in the ALR group were administered altrenogest. Serial blood samples were 
collected during estrus throughout the duration of the study period. Data are reported as 
mean ± S.E.M. The mean daily progesterone concentration from ovulation to altrenogest 
administration on Day 5 remained < 1.0 ng/mL in the AL group compared to the control 
group where concentrations rose > 2.4 ng/mL on Day 3 and were significantly different 
on Days 4 through 11 and Days 14 and 16. Pregnancy rate was significantly different 
with 50% in the ALR groups vs. 100% in the control group (p < 0.05). The embryonic 
vesicle size was significantly smaller on days 14 and 15 (p < 0.05) of pregnancy in the 
ALR compared to the control group. The delayed vesicle size in the ALR group did catch 
up to the control group and heartbeats were detected on either Day 22 or 23 in both 
groups. This study demonstrated that although embryo development and pregnancy can 
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occur in a progesterone-deprived environment normal growth and development may be 
altered.  
4.2 Introduction 
 In mammals, progesterone is the solitary hormone required for the establishment 
and maintenance of pregnancy [4.1]. Progesterone is responsible for maintaining uterine 
quiescence and most importantly for the production of the uterine histotroph [4.2-4.4]. In 
the mare, the uterine histotroph contains many progesterone-mediated components such 
as P19, a lipocalin essential to the formation of the embryonic capsule [4.5, 4.6]. During 
the first 40 days of gestation in the mare a high rate of pregnancy failure can occur [4.1, 
4.7]. This time period is divided into two phases, with the first period defined as day 0 
(fertilization) to 13 and the second period from day 14 to 40 [4.7].  The incidence of 
embryonic loss during the first period in young fertile mares is reported to be 9% and can 
be as high as 73% in older mares or those with decreased fertility [4.7]. Early embryonic 
loss in the mare has a significant economic impact on the horse industry [4.7]. A variety 
of factors contribute to early embryonic loss, and these factors include hypoluteoidism, 
resulting in insufficient progesterone concentrations [4.1, 4.7]. Increased embryonic 
survival in the mare is associated with progesterone concentrations > 4 ng/ml [4.8]. 
 Progesterone rises sharply after ovulation in the mare [4.9]. Due to this steep rise 
almost immediately after ovulation, progesterone is the predominant hormone present 
during early embryogenesis. Changes to the embryonic environment that occur within the 
first few days of development can have significant effects on subsequent fetal 
development [4.10]. The embryonic environment post-ovulation is of particular 
importance in the mare due to the extended period of embryo migration from the uterine 
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tube to the uterus, which lasts approximately 6 days [4.11]. Furthermore, studies have 
shown that the uterine tube ipsilateral to ovulation has elevated concentrations of 
progesterone in both the tissue and fluid [4.12]. Additionally, the mare also has a 
prolonged period of embryo migration and delayed implantation compared to other 
domestic species [4.13]. Appropriate uterine tube environment and proper priming of the 
uterus supported by adequate progesterone levels are essential for successful pregnancy 
establishment in the mare.  
 Studies in the mare have evaluated the importance of adequate progesterone 
production beginning immediately post-ovulation. Progesterone production from the 
newly formed CL beginning as early as 2 days post-ovulation can have a significant 
effect on the successful establishment of pregnancy [4.14-4.16]. One study has 
demonstrated that equine in vivo embryos produced in a progesterone-deprived 
environment are developmentally delayed [4.17]. The embryos produced were subjected 
to a continued period of progesterone-deprivation from Day 0 to 8 whereas other studies 
have involved only a transient loss of progesterone levels [4.14-4.17].  
 One question to answer is the viability of embryos subjected to an extended 
period of progesterone-deprivation beginning immediately post-ovulation, comparable to 
hypoluteoidism, and if these challenged embryos can establish a normal pregnancy. This 
study was developed to evaluate the viability of embryos developed during induced 
aluteal cycles characterized by plasma progesterone < 1.0 ng/mL in the mare. We 
hypothesized that embryos deprived of progesterone during the periovulatory period 
(Days 0 to 4) and then “rescued” by administration of altrenogest on Day 5 would be 
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developmentally delayed, as indicated by smaller embryonic vesicle diameter and 
delayed detection of a heartbeat.  
4.3 Materials and Methods 
 The Institutional Animal Care and Use Committee of Louisiana State University 
School of Veterinary Medicine approved all experimental protocols. The work was 
performed in a USDA-registered National Institute of Health-assured, and AAALAC 
International accredited animal facility in accordance with The Guide for the Care and 
Use of Laboratory Animals [4.18]. Eight cyclic light horse mares (4 Quarter Horse, 4 
Thoroughbred) with a median age of 8 years (range 4-16) were utilized in a crossover 
design during October, 2015, and July to September, 2017, in Baton Rouge, LA.  
 Mares were monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm, 
Bothell, WA) throughout the study period. Mares in estrus as determined by the presence 
of uterine edema and with a follicle > 35 mm diameter were treated once with human 
chorionic gonadotropin (hCG, 2000 IU, IV, Chorulon, Merck Animal Health, 
Kenilworth, NJ). Mares were artificially inseminated every other day until ovulation was 
detected with ≥ 1 x 109 total motile spermatozoa from one stallion of known fertility. 
Reproductive examinations by ultrasonography were performed twice daily after 
insemination until detection of ovulation. After ovulation, mares were randomly assigned 
to one of two treatment groups: control (normal diestrus) or induced aluteal rescue 
(ALR). The ALR mares were treated according to a protocol previously described [4.19]. 
Briefly, mares were treated once daily with PGF2α (10 mg, IM, Lutalyse, dinoprost 
tromethamine, Zoetis, Florham Park, NJ) on Days 0 through 4 [4.19]. On Day 5 post-
ovulation, mares in the ALR group were administered long acting biorelease altrenogest 
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(225 mg, IM; BET Pharm, Lexington, KY) [4.19]. The control group was treated on the 
same schedule with saline solution (2 mL. IM). Mares in both groups were evaluated for 
pregnancy by reproductive ultrasonography on Days 12, 13, 14, 15, 17, and 22, or until 
Day 14 if not pregnant, and embryonic vesicle diameter was recorded if pregnant. 
 Serial blood samples were collected from the time mares ovulated (Day 0) until 
detection of heartbeat (Days 22 or 23) if pregnant in both control and ALR groups. 
Plasma was harvested and stored at -20° C until assayed for progesterone. Concentrations 
of plasma progesterone for all cycles resulting in a pregnancy were determined by a 
progesterone radioimmunoassay (RIA). For the progesterone RIA, both the intraassay 
and interassay coefficients of variants were < 15%. A technician blinded to treatment 
protocols and groups performed the progesterone assays using a MP Biomedical double 
antibody approach as previously described [4.20]. 
 Normality of data was confirmed and statistical significance for all data analyses 
was set at P ≤ 0.05. Data for embryo vesicle diameter and concentrations of plasma 
progesterone were analyzed by ANOVA for repeated measures and data for pregnancy 
rate was analyzed by a student’s t-test (Sigma Plot V14.0, Systat Software, San Jose, 
CA). Data are expressed as mean ± SEM.  
4.4 Results 
 The overall mean progesterone concentration throughout the study duration (Day 
0 to Day 23) was significantly different between groups. The ALR group remained < 1.0 
ng/mL with an overall concentration of 0.86 ± 0.58 ng/mL compared to the control group 
overall concentration of 3.76 ± 0.54 ng/mL (p < 0.001). The mean daily progesterone 
concentration from ovulation (Day 0) to altrenogest administration on Day 5 differed 
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significantly in the ALR group compared to the control, 0.35 ± 0.16 ng/mL vs. 2.50 ± 
0.25 ng/mL respectively (p < 0.001) (Fig. 4.1). The mean concentration of progesterone 
in the control group reached 2.43 ng/mL on Day 3 in contrast to a mean concentration of 
0.69 ng/mL in the ALR group (Fig 4.1). Concentrations of plasma progesterone differed 
significantly between control vs. ALR group beginning on Day 4, remained so until Day 
11 and was also significantly different on Days 14 and 16 (p < 0.05) (Fig. 4.1).  
 
 
Fig. 4.1. Mean (± S.E.M.) daily concentrations of plasma progesterone in control and 
induced aluteal rescue treatment groups. During the induced aluteal treatment, note that 
serial administration of PGF2α immediately post-ovulation once daily on Days 0 through 
4 caused the mean daily concentrations of plasma progesterone to remain < 1.0 ng/mL 
from Day 0 through Day 19. This is in contrast to the control (luteal) cycle where 
progesterone rose > 2.4 ng/mL on Day 3. The mean daily concentrations of plasma 
progesterone differed significantly in control vs. aluteal group beginning on Day 4 and 
remained so until Day 11 and also on Days 14 and 16 (*; p < 0.05) 
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 A significant difference was observed in the pregnancy rate between the ALR 
group and the control group; 50% (4/8) compared to 100% (4/4) respectively (p < 0.05). 
Overall, the size of the embryonic vesicles in the AL group was smaller than the control 
group (Table 14., Fig. 4.2).  A significant difference was observed in the size of the 
vesicles in the ALR group on Days 14 and 15 (p < 0.05) of pregnancy compared to the 
control group (Table 4.1, Fig. 4.2).  
 
Table 4.1 Mean (± S.E.M.) embryonic vesicle diameter on different days post-ovulation 
in control and induced aluteal rescue (ALR) treatment groups. The embryonic vesicle 
size is smaller on all days examined in ALR vs. control, with a significant difference 
observed on Days 14 and 15. 
Day of cycle 





12 4.55 ± 1.05 8.67 ± 1.33 
13 8.03 ± 1.05 12.50 ± 1.04 
14 12.01 ± 1.15a 17.75 ± 1.32b 
15 16.10 ± 1.23a 22.25 ± 0.63b 
17 24.50 ± 1.11 27.25 ± 0.48 
a, b; p < 0.05 
 
A heartbeat was detected on either Day 22 or 23 in all pregnancies (control and ALR). 
Two of the pregnant mares in the ALR group ovulated a secondary CL during pregnancy. 
One mare ovulated the secondary CL at Day 13 and one mare at Day 16.  
4.5 Discussion 
 The present study evaluated the effects of progesterone-deprivation during the 
periovulatory period on embryo survival and early pregnancy development in the mare. 
Progesterone-deprived (aluteal) cycles defined by mean plasma progesterone < 1.0 
ng/mL were induced in all mares subjected to serial PGF2α treatments in the ALR group 
from Day 0 until altrenogest administration on Day 5. Delayed embryonic development 
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was noted in the ALR group with overall embryonic vesicle diameter smaller than the 
control group on Days 12-15, and 17. The delayed vesicle size in the ALR group did 
catch up to the control group and heartbeats were detected on either Day 22 or 23 in both 
groups. This study has provided new information about progesterone deprivation during 




Fig. 4.2. Mean (± S.E.M.) embryonic vesicle diameter in control and induced aluteal 
rescue treatment groups. The diameter of the embryonic vesicle is significantly different 
in control vs. AL mares on Days 14 and 15. (*; p < 0.05) 
 
 Concentrations of plasma progesterone were significantly altered in the ALR 
group compared to controls. Serial administration of PGF2α once daily (antiluteogenic 
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treatments) altered normal CL development and function. Long acting altrenogest was 
administered Day 5 post-ovulation. This synthetic progestagen has a proven bioactivity 
for the progesterone receptor in the mare [4.21]. It has been demonstrated that 
progesterone is the only hormone required for the maintenance of pregnancy in a variety 
of ways. In one study ovariectomized mares remained pregnant after embryo transfer 
when supplemented only with progesterone [4.22]. Progesterone is essential for the 
production of uterine histotroph, the primary conceptus nutrition until placentation [4.22, 
4.23]. Inadequate levels of progesterone are not compatible with pregnancy and increased 
embryonic loss is more likely to occur when progesterone is < 2.0 ng/mL [4.8].  
 A difference was observed in conceptus growth during Days 12-17 when they 
were deprived of progesterone during the periovulatory period. These results demonstrate 
that the presence of progesterone significantly affects early conceptus development in the 
mare. This is in agreement with studies conducted in sheep that found enhanced fetal 
growth when progesterone was administered during the first three days of pregnancy 
[4.10]. Increased embryo survival and improved development was also seen in cattle 
when progesterone was supplemented during the periovulatory period [4.24]. In the 
present study pregnancies deprived of progesterone from Day 0 to Day 5 had delayed 
development characterized by a smaller vesicle size than control counterparts. One study 
demonstrated that the expression of progesterone-mediated endometrial transcripts 
related to pregnancy and conceptus nutrition is affected during induced aluteal cycles 
[Chapter 3]. The retarded pregnancy during the present study was likely caused by the 
altered hormonal milieu present in the AL cycles and the subsequent effects on the 
uterine environment. 
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 The equine conceptus initiates steroidogenesis as early as Day 6 with measurable 
amounts of progesterone, androgens, and estrogens isolated from Day 8 embryos [4.25]. 
At Day 12, significant quantities of estrogens are produced and this continues until Day 
20 [4.25, 4.26]. These conceptus-derived estrogens act via endometrial estrogen receptors 
and influence uterine function in a way that remains to be elucidated [4.27]. It has been 
demonstrated that equine embryos produced in an in vivo progesterone-deprived 
environment are developmentally delayed and of lower quality than embryos developed 
during normal diestrus with elevated progesterone [4.17]. Additionally, expression of 
progesterone-mediated transcripts is altered when in vivo embryos are progesterone-
deprived [Chapter 3].  
 The ALR cycles resulted in a significantly lower pregnancy rate compared to 
control cycles. Other studies in the mare have also demonstrated that pregnancy rate is 
affected when luteal function is disturbed during the periovulatory period [4.14-4.16]. 
Although this study was not able to distinguish between fertilization failure and embryo 
loss, a fertile stallion, young mares and a crossover design was used. Treatment mares 
served as controls and having achieved a 100% pregnancy rate in the control group, it is 
our assumption that fertilization failure is not a factor in this study. The results of the 
present study concur with similar studies that indicate sufficient concentrations of 
progesterone are essential during the periovulatory period to successfully establish 
pregnancy [4.14-4.16].  
4.6 Conclusions 
We have demonstrated that embryo development and pregnancy can occur in a 
progesterone-deprived environment. Normal embryonic growth and development were 
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altered, but each successful conceptus was able to reach the appropriate parameters by the 
time a heartbeat developed. Furthermore, pregnancy rate was significantly affected by 
progesterone-deprivation. Future studies to evaluate the effects of periovulatory 
progesterone-deprivation on the placentation and epigenetic programming of the fetus are 
warranted. 
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CHAPTER 5: EVALUATING THE EFFECTS OF AN INDUCED ALUTEAL 
CYCLE ON THE FERTILITY OF SUBSEQUENT EMBRYO COLLECTIONS  
 
5.1 Summary 
A 3-year-old Thoroughbred mare underwent 3 consecutive embryo collection 
cycles to evaluate the effects of an induced aluteal cycle on the fertility of subsequent 
embryo collections. In the first cycle (Cycle 1), antiluteogenic treatments were 
administered resulting in an aluteal cycle (daily progesterone < 1.0 ng/mL). Embryo 
collection was performed 8 days post-ovulation. At the time of embryo collection during 
Cycle 1 the mare was in estrus with 2 follicles > 35 mm and the presence of uterine 
edema as determined by reproductive ultrasonography. The mare was artificially 
inseminated the day of embryo collection and two embryos were successfully collected 8 
days post-ovulation (Cycle 2). The mare was monitored for a return to estrus and 
artificially inseminated when a follicle ≥ 35 mm was detected. A successful embryo 
collection was performed 8 days post-ovulation (Cycle 3). Cycle 2 and 3 were normal 
(luteal) cycles demonstrated by a normal post-ovulatory rise in progesterone ranging 
from 8 to 30 ng/mL. The interovulatory interval between Cycle 1 and 2 was 10 days 
which was significantly different from the interovulatory interval between Cycles 2 and 
3, which was 17 days (p < 0.05). This case report describes an embryo collection from a 
mare during an aluteal cycle followed by successful consecutive embryo collections 
during normal (luteal) cycles. To our knowledge, this is the first report of an embryo 
collection from a mare in estrus, followed by a subsequent embryo recovery after 





 In the horse, embryo collections are typically performed on Days 7 or 8 after 
ovulation, a time when concentrations of blood progesterone are elevated [5.1, 5.2]. 
Blastocysts or expanded blastocysts are the developmental stages commonly identified in 
embryos recovered during that period [5.3]. For mares that are enrolled in programs of 
repeated embryo collections, a luteolytic injection of PGF2α is commonly administered 
shortly after embryo collection to allow a return to estrus and an opportunity for a new 
breeding [5.4]. The time to return to estrus and subsequent ovulation is variable because 
mares may be at different stages of follicle development at the time of PGF2α 
administration.  Ovulation following PGF2α treatment may occur as early as 3 to 5 days 
following the luteolytic treatment or take as long as 11-13 days. This variation in 
ovulation is due to differences in follicle size when PGF2α is administered. On average, 
most mares ovulate 7 to 10 days following PGF2α treatment. Therefore, it is not unusual 
for several days to elapse between the day of the embryo flush and the day of the next 
breeding.  
In the present report, we describe the successful embryo collection from a mare 
during an aluteal cycle followed by successful consecutive embryo collections during 
normal (luteal) cycles. The mare was in estrus on the day embryo collection was 
performed during the aluteal cycle. To our knowledge, this is the first report of an 
embryo collection from a mare in estrus, followed by another embryo recovery after 




5.3 Materials and Methods  
 A 3-year-old Thoroughbred mare underwent 3 consecutive embryo collection 
cycles. The mare was monitored by transrectal ultrasonography (SonoSite Edge, Fujifilm, 
Bothell, WA). Reproductive ultrasonography was used to identify signs of estrus as 
follows: the presence of a follicle ≥ 35 mm diameter, marked endometrial edema and the 
absence of luteal tissue. All artificial inseminations were performed with ≥ 1 x 109 total 
motile fresh spermatozoa obtained from one stallion of known fertility. 
 On the first estrus, the mare was artificially inseminated and treated with hCG 
(2000 IU, IV, Chorulon, Merck Animal Health, Kenilworth, NJ). The mare was then 
examined twice daily to determine the occurrence of ovulation. Once ovulation was 
detected (Day 0), the mare was subjected to antiluteogenic treatments (AL) as previously 
described [5.5, 5.6]. Briefly, PGF2α (dinoprost tromethamine, 10 mg, IM, Lutalyse, 
Zoetis, Florham Park, NJ) was administered twice daily on days 0, 1, and 2 and once 
daily on days 3 and 4. Daily blood samples were collected from breeding until the day of 
embryo collection on Day 8. Embryo collection was performed in an aseptic manner 
using Lactated Ringers Solution (LRS) with no supplementation (MWI Veterinary 
Supply, Boise, ID). The uterus was lavaged with 0.5 to 1 L of LRS at a time and a total of 
4 L of LRS was used at each embryo collection. Once an embryo was identified it was 
classified according to stage of development, photographed and the diameter measured.  
 A morula 178 µm in diameter was collected on Day 8 post-ovulation from the 
first embryo collection. (Fig. 5.1). On the day the morula was collected, the mare was in 
estrus as determined by receptivity when teased to a stallion and reproductive 
ultrasonography with two preovulatory follicles measuring 41 and 35 mm in diameter, 
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and the presence of uterine edema 2 (scale of 0 to 4); the corpus luteum could no longer 
be detected. Approximately 2 hours following embryo collection, the mare was 
artificially inseminated and administered hCG. Two ovulations were confirmed by 
transrectal ultrasonography and another embryo collection was performed on Day 8 post 
ovulation resulting in the successful recovery of two expanded blastocysts measuring 
1056 and 1031 µm (Fig. 5.1).   
 Immediately following this second embryo collection, the mare was treated with a 
single injection of PGF2α (dinoprost tromethamine,10 mg, IM; Lutalyse, Zoetis, Florham 
Park, NJ) and monitored for a return to estrus. Seven days after embryo collection, a 40-
mm follicle was detected in the presence of uterine edema as detected by reproductive 
ultrasonography. On that day, the mare was artificially inseminated and administered 
hCG. Ovulation was detected 48 hours post-breeding and a third consecutive embryo 
collection was performed on Day 8, resulting in the recovery of an expanded blastocyst 
measuring 1510 µm (Fig 5.1).  
 Plasma samples were analyzed for progesterone concentrations using an 
automated fluorometric enzyme immunoassay analyzer (AIA 360®, Tosoh Bioscience, 
Inc., South San Francisco, CA), as previously described for horse plasma [5.7]. 
5.4 Results  
 The administration of serial PGF2α was successful in inducing an aluteal cycle as 
demonstrated by the daily plasma progesterone concentration during the first cycle 
remaining < 1.0 ng/mL during the postovulatory period (Fig. 5.2). In contrast, during the 




Fig. 5.1. Embryos collected 8 days post-ovulation from consecutive cycles. During Cycle 
1 the embryo collected was classified as a morula and measured 178 µm in diameter (a). 
A synchronous double ovulation was detected during Cycle 2 and two expanded 
blastocysts measuring 1056 and 1031 µm in diameter were collected (b and c 
respectively). An expanded blastocyst 1510 µm in diameter was collected during Cycle 3, 
a normal (luteal) cycle (d).  
 
In the present report, a remarkable interval of only 10 days elapsed between the 
first two consecutive collections of 8-day old embryos.  This was significantly different 
than the 17 day interval between the second and third embryo collections (p < 0.05). This 
10-day interval was possible because 1) the mare was in estrus on the day the first 
embryo collection was performed and she was artificially inseminated two hours after the 
successful embryo collection, and 2) she ovulated within 48 hours of hCG administration.   
5.5 Discussion 
As previously reported, serial administration of PGF2α beginning within 12 hours of 
ovulation prevented normal corpus luteum function as confirmed by reproductive 
ultrasonography and daily concentrations of plasma progesterone remaining < 1 ng/mL 
[5.5, 5.6]. In agreement with our first report describing that early embryonic development 




(a)	 (b)	 (c)	 (d)	( )		
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Fig. 5.2. Mean (± S.E.M.) daily concentrations of plasma progesterone (ng/mL). During 
cycle 1, the induced aluteal cycle, there was no rise in plasma progesterone with daily 
concentrations remaining < 1.0 ng/mL. This is in contrast to cycles 2 and 3, the normal 
(luteal) cycles, where a post-ovulatory rise in progesterone was observed. The elevated 
plasma progesterone concentration was sustained during the diestrus period until PGF2α 
was administered on the day of embryo collection (Day 8). 
 
cycle in the present report [5.5]. The embryo was classified as a morula, denoting marked 
delayed development. Its viability could not be ascertained as the aluteal embryo was 
processed and frozen for future analysis. In a previous study, 4 mares that were 
artificially inseminated and underwent serial PGF2α treatments following ovulation were 
treated with injectable altrenogest on Day 6 after ovulation in an attempt to rescue a 
potential developing pregnancy [5.8]. Two mares became pregnant and heartbeats were 
detected at Day 22 in both pregnancies [5.8]. In the present report, the embryo collected 
during the aluteal cycle was developed in a progesterone-deprived environment and the 
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mare was already in estrus on the day of embryo collection. It is plausible to speculate 
that the viability of that embryo was significantly compromised. Therefore, the viability 
of aluteal embryos on Day 8 after ovulation remains to be determined by embryo 
collection and transfer to synchronized luteal recipient mares or following rescue by 
administration of exogenous progestagens as described in our previous report [5.8].  
Equine practitioners have reported the effect of repeated breeding and embryo 
flushes on the fertility of embryo donor mares. In one report, 27 embryos were recovered 
from 70 embryo flushes, yielding an embryo recovery rate of 38.6% [5.1]. In the 
subsequent year, 15 embryos were produced in 21 embryo flushes, resulting in 71% 
embryo recovery rate [5.1]. The authors concluded that repeated breeding and embryo 
collection attempts did not affect the fertility of embryo donor mares [5.1]. In another 
study, 21 mares were subjected to repeat artificial inseminations and embryo flushes 
(average of 7 per mare) [5.9]. In this study, the breeding and embryo transfer procedures 
were associated with increased chronic inflammation but the future fertility of those 
mares was not investigated [5.9]. In the present report, four embryos were recovered 
during three consecutive embryo flushes. Three morphologically normal, grade 1 
expanded blastocysts were recovered in the two luteal cycles following the first aluteal 
cycle. These results are in agreement with our previous reports that showed the potential 
for pregnancy or embryo production remains the same for mares ovulating and subjected 
to antiluteogenic treatments and for mares artificially inseminated in the post-aluteal 
cycle [5.5, 5.6]. Interestingly, as previously reported, the collection of an endometrial 
biopsy during estrus does not affect the likelihood of pregnancy [5.10]. In the present 
report, two endometrial biopsies were taken immediately after embryo collection and 
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approximately 2 hours prior to artificial insemination.  Embryos were collected in the 
subsequent cycle, illustrating how the collection of an endometrial biopsy during estrus 
does not seem to affect the chance for pregnancy in mares artificially inseminated on that 
cycle [5.10]. 
5.6 Conclusions 
 To our knowledge, this is the first report of an embryo collection from a mare in 
estrus, followed by artificial insemination the same day and subsequent embryo 
collection occurring 10 days after the previous embryo collection. Further investigation is 
warranted to utilize serial treatments of PGF2α applied at different times during the 
periovulatory period to shorten the interovulatory interval and embryo collection 
efficiency in the mare. Additionally, investigation of the viability of embryos produced in 
an aluteal environment can be evaluated utilizing embryo transfer. 
3.7 References 
[5.1] Tischner M, Bielański A. Non-surgical embryo collection in the mare and 
subsequent fertility of donor animals. J Reprod Fertil. 1980;58(2):357-61. 
 
[5.2] Squires EL, McCue PM, Vanderwall D. The current status of equine embryo 
transfer. Theriogenology 1998;51:91-104. 
 
[5.3] McCue PM, DeLuca CA, Ferris RA, Wall JJ. How to evaluate equine embryos. 
AAEP Proceedings 2009;55:252-6. 
 
[5.4] Campbell ML. Embryo transfer in competition horses: Managing mares and 
expectations. Equine Vet Educ. 2014;26(6):322-7. 
 
[5.5] Leisinger CA, Medina V, Markle ML, Paccamonti DL, Pinto CRF. Morphological 
evaluation of Day 8 embryos developed during induced aluteal cycles in the mare. 
Theriogenology 2018;105:178-83. 
 
[5.6] Coffman EA, Pinto CR, Snyder HK, Leisinger CA, Cole K, Whisnant CS. 




[5.7] Scott B. (2011). Development and permeability of equine blastocysts (unpublished 
master’s thesis). Louisiana State University, Baton Rouge, Louisiana. 
 
[5.8] Leisinger CA, Davolli GM, Foster BA, Whisnant CS, Paccamonti DL, Pinto CRF. 
In vivo embryo production during induced aluteal cycles in the mare. Clinical 
Theriogenology 2016;8:333. 
 
[5.9] Carnevale E, Beisner AE, McCue PM, Bass LD, Squires EL. Uterine changes 
associated with repeated inseminations and embryo collections in mares. Reproduction 
2005;51:202-3. 
 
[5.10] Watson ED, Sertich PL. Effect of repeated collection of multiple endometrial 
biopsy specimens on subsequent pregnancy in mares. J. Am. Vet. Med. Assoc. 
1992;201:438–40.  
	 86	
CHAPTER 6: SUMMARIZING DISCUSSION AND CONCLUSIONS 
6.1 Discussion  
 A novel in vivo model was utilized to evaluate the effects of progesterone 
deprivation on the Day 8 embryo and endometrium. Additionally, embryos developed in 
a progesterone-deprived environment were subsequently rescued by administration of 
altrenogest to evaluate the effects of early progesterone deprivation on normal pregnancy 
establishment. The administration of serial doses of PGF2α resulted in mean plasma 
progesterone < 1.0 ng/mL in all AL groups (Chapters 2-5). This contrasted greatly with 
control groups, which displayed a typical diestrus rise up to 10 ng/mL and created a 
clearly altered hormonal milieu in control vs. AL groups. The morphological and 
molecular characterization of Day 8 embryos in AL vs. control cycles demonstrated that 
lack of progesterone adversely affects embryo quality and alters the expression of certain 
genes in both the embryos and endometrium (Chapter 2 and 3). The AL cycles 
subsequently rescued by altrenogest administration significantly affected pregnancy rate 
and normal pregnancy development (Chapter 4). The administration of serial doses of 
PGF2α significantly decreased the interovulatory interval (IOI) and had no effect on 
future fertility with the successful collection of three embryos from two subsequent 
normal diestrus cycles after an AL cycle (Chapter 5).  
 The model utilized in the present studies is an established model that administers 
serial doses of PGF2α within 12 hours of ovulation to prevent normal luteal function 
(antiluteogenesis) in the mare [6.1-6.6]. This model reliably results in mean plasma 
progesterone < 1.0 ng/mL throughout the duration of the typical diestrus period in the 
mare. When the established model administering 8 serial doses of PGF2α was utilized in 
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this work, aluteal cycles, as defined by mean plasma progesterone < 1.0 ng/mL, were 
induced and maintained in all treated cycles throughout the study period (Day 0 to Day 8) 
(Chapters 2-4). When the protocol was modified to administer PGF2α once daily for 4 
days beginning within 12 hours of ovulation, aluteal cycles were induced in all treated 
mares from Day 0 to the time of altrenogest administration on Day 5 (Chapter 5).  
 Embryos produced during AL cycles were affected compared to control embryos 
produced during normal diestrus (high progesterone) cycles (Chapter 2). It has been 
established that the equine embryo expresses non-genomic progesterone receptors as 
early as Day 7 [6.7]. The effects of the altered hormonal milieu were detected in the 
morphology of the Day 8 AL embryos as well as in the gene expression. The majority of 
the Day 8 AL embryos collected were significantly smaller in diameter, earlier in 
development, and lower in quality grade. Typically, the stage of embryo recovered at a 
Day 8 embryo collection would be an expanded blastocyst visible to the naked eye 
measuring between 500-1000 μm [6.8]. The AL embryos were classified as morula and 
early blastocysts with diameters between 151-195 μm compared to the expanded 
blastocysts between 600-1122 μm in diameter in the control group.  
 The transcript expression of AL embryos and endometrium was affected (Chapter 
3). The AL embryos had a significantly increased expression of four genes ESR1, P19, 
APOB and PGR.  It has been described that steroid hormones mediate the expression of 
ESR1, PGR and P19 [6.7, 6.9, 6.10]. The upregulation of these transcripts is likely due to 
the lack of progesterone during AL cycles which mimics estrus vs. diestrus. The 
upregulation of APOB, a transcript related to nutrient transport and embryo development, 
complements the results of the developmentally delayed and lower quality AL embryos 
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[6.11]. The upregulation of this transcript may be an attempt to increase nutrient uptake 
and compensate for nutrient deficiencies experienced during progesterone-deprivation. In 
the endometrium four transcripts were upregulated, FGF9, sPLA2, PGR, ESR1, and four 
transcripts were downregulated, HK2, P19, IFNE, CTGF. Steroid hormones drive the 
expression of sPLA2, PGR, ESR1, HK2, P19, FGF9 and IFNE [6.9, 6.10, 6.12-6.25]. The 
altered expression of these transcripts is likely due to the absence of progesterone during 
induced aluteal cycles. The remaining transcript, CTGF, is a growth factor implicated in 
the maintenance of early pregnancy in the mare [6.26]. It is likely that the endometrial 
development in a progesterone-deprived environment during AL cycles negatively 
affected the signaling events required for the appropriate expression of CTGF. 
 It was demonstrated that embryos deprived of progesterone during the early 
preimplantation period (Day 0 to Day 4) and rescued by the administration of altrenogest 
displayed delayed embryonic vesicle growth overall compared to controls as 
characterized by a smaller diameter on Days 12-15 and 17 (Chapter 4). However, the 
rescued AL pregnancies were able to establish normal pregnancy parameters as 
determined by the detection of a heartbeat at Days 22 or 23. This study is in agreement 
with other studies that sufficient concentrations of progesterone are essential during early 
the early postovulatory period to establish pregnancy [6.27, 6.28]. The AL cycles also 
resulted in a significantly lower pregnancy rate compared to control cycles. Other studies 
in the mare have also demonstrated that pregnancy rate is affected when luteal function is 
disturbed during the periovulatory period [6.27, 6.28]. 
 It has been demonstrated that the application of antiluteogenic treatments results 
in a shortened IOI with no effect on the fertility of subsequent cycles [6.1, 6.6]. 
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Remarkably, a 10-day interval was recorded between two consecutive embryo collections 
after an induced aluteal cycle (Chapter 5). Additionally, the two successful embryo 
collections occurred during the cycles immediately following an induced aluteal cycle. 
Conflicting reports exist regarding repeated embryo collections in the mare. Some 
practitioners report an increase in chronic inflammation and others see no difference on 
the fertility of donor mares [6.29, 6.30]. In the present study four embryos were collected 
from three consecutive cycles indicating there was no effect on fertility when 
antiluteogenic treatments and repeated embryo collections were employed in a young, 
fertile mare. 
6.2 Conclusions 
 The present studies characterize the importance of adequate progesterone levels 
beginning immediately post-ovulation and continuing throughout the early 
preimplantation period and early pregnancy in the mare. The results of this work 
demonstrate that progesterone is a key mediator in early embryonic growth and 
development. Progesterone plays an important role in the preparation of the endometrium 
so pregnancy can be established and maintained. The effects of progesterone on the 
preimplantation embryo may be both direct via non-genomic steroid receptors and 
indirect via the improperly primed endometrium and inadequate uterine histotroph. 
Furthermore, although early pregnancies were affected by progesterone-deprivation, the 
administration of an exogenous progestagen rescued the pregnancy and the developing 
conceptus was able to reach normal pregnancy parameters up to Day 23. The lasting 
effects of progesterone deprivation on the embryo and pregnancy viability have yet to be 
determined. Future studies transferring progesterone-deprived embryos to synchronized 
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luteal recipients may offer additional information. Additionally, modifications of the 
protocol used to induce the aluteal cycles may be applied to shorten the interovulatory 
interval and increase reproductive efficiency of embryo donor mares. 
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